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Rustokudoksen paranemiskyky on hyvin rajoittunutta eivätkä nykyiset kliiniset metodit 
tarjoa varmaa tapaa uuden toiminnallisen rustokudoksen aikaansaamiseksi. Viime 
vuosikymmeninä ruston korjaukseen liittyvä tutkimus on keskittynyt yhä enemmän 
kudosteknologisiin ratkaisuihin, jotka tarjoavat skaffoldi-pohjaisia strategioita uuden 
ruston muodostamiseksi. Kollageenin (COL) ja kahden glykosaminoglykaanin, 
kondroitiinisulfaatin (CS) ja hyaluronihapon (HA) yhdistäminen on saanut osakseen 
laajaa mielenkiintoa, sillä kaikki kolme ovat natiivin rustokudoksen peruskomponentteja. 
Tämän diplomityön tavoitteena oli valmistaa ruston kudosteknologiaan soveltuvia 
COL, HA ja/tai CS skaffoldeja ja tutkia niiden ominaisuuksia. Huokoiset kolmiulotteiset 
skaffoldit valmistettiin kylmäkuivaamalla ja ristisilloitettiin käyttäen joko 1-etyyli-3-(3-
dimetyyliaminopropyyli)-karbodi-imidi hydrokloridi / N-hydroksisukkiini-imidia 
(EDC/NHS) tai genipiniä (GP). Valmistettujen COL+CS/HA/CS+HA skaffoldien 
ominaisuuksia tutkittiin puristus- ja nesteenimeytymistestein,  
mikrotietokonetomografialla sekä Fourier-muunnos infrapunaspektroskopialla (FTIR). 
Yleisesti ottaen, 80 wt.% COL komposiittiskaffoldit kestivät valmistuksen ja 
ristisilloituksen 60 wt.% COL komposiittiskaffoldeja paremmin. Lisäksi ne imivät 60 
wt.% skaffoldeja enemmän vettä. Myös GP-ristisilloitettujen ja COL+HA skaffoldien 
vedenottokyvyn havaittiin  olevan EDC/NHS-ristisilloitettuja ja COL+CS skaffoldeja 
suurempi. Veden imeytymistesteissä kaikkien skaffoldien turpoaminen/kutistuminen 
huomattiin pysyvän alle 20%:ssa; suurimmaksi osaksi muutokset olivat noin 10%:n 
luokkaa. FTIR-tulokset varmistivat ristisilloituksen tapahtuneen kaikissa GP ja 
EDC/NHS käsitellyissä skaffoldeissa. Mikrotietokonetomografia mittaukset paljastivat 
kaikkien skaffoldien olevan erittäin huokoisia (88-94%) ja huokoset toisiinsa liittyneitä 
(mitatut huokoskoot 26-57 µm).  
Kuivien skaffoldien puristuslujuus oli huomattavasti suurempi kuin vastaavien 
märkien skaffoldien; suurin ero havaittiin GP-ristisilloitettujen skaffoldien välillä. 
Korkeimmat puristusmodulit, niin kuivilla kuin märillä skaffoldeilla, mitattiin CS:ää 
sisältävistä komposiiteista. Kahdesta COL:ia ja HA:a sisältävästä skaffoldiryhmästä taas 
mitattiin pienimmät puristusmodulit. Kaikki skaffoldit (märkinä että kuivina) palautuivat 
hyvin puristuksesta. 
Tässä diplomityössä onnistuttiin valmistamaan kylmäkuivaamalla erittäin huokoisia, 
kolmiulotteisia ja ruston kudosteknologiaan soveltuvia COL+CS/HA/CS+HA  
skaffoldeja. Lisäksi, GP osoittautui ristisilloittajana lupaavaksi vaihtoehdoksi 
perinteiselle EDC/NHS:lle.  
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Native cartilage has very little capacity for self-healing and even the current clinical meth-
ods have limited ability to regenerate functional cartilage. In the recent decade research 
related to cartilage repair has been increasingly focused on tissue engineering solutions 
that offer scaffold-based strategies for new cartilage formation. The combination of col-
lagen (COL) with two glycosaminoglycans, chondroitin sulfate (CS) and hyaluronic acid 
(HA) has received widespread interest because all three are naturally abundant in the na-
tive cartilage tissue.  
The objective of this thesis was to fabricate and characterize COL, HA and/or CS 
containing scaffolds applicable for cartilage tissue engineering. Porous 3D scaffolds were 
fabricated by freeze-drying and cross-linked with either 1-ethyl-3-(3-dimethylaminopro-
pyl)-carbodiimide hydrochloride / N-hydroxysuccinimide (EDC/NHS) or genipin (GP). 
Fabricated COL+CS/HA and COL+CS+HA scaffolds were characterized by compression 
and water uptake testing, Fourier transform infrared (FTIR) spectroscopy and micro-com-
puted tomography (micro-CT) imaging.       
In general, the 80 wt.% COL containing composite scaffolds endured fabrication and 
both cross-linking procedures better than the 60 wt.% COL containing composite scaf-
folds. Water uptake ability was higher in GP cross-linked versus EDC/NHS cross-linked 
scaffolds, in the 80 wt.% COL containing versus 60 wt.% COL containing scaffolds and 
in COL+HA versus COL+CS composite scaffolds. The swelling/shrinkage upon water 
uptake of all of the scaffolds was below 20%; in most cases around 10%. FTIR spectra 
confirmed successful cross-linking with both GP and EDC/NHS and micro-CT images 
revealed highly porous microstructure (88-94%) with interconnected pores (pore sizes 
26-57 µm) in all the scaffolds.  
The dry scaffolds had significantly higher compressive modulus than the correspond-
ing wet scaffolds; the difference being bigger with GP cross-linked scaffolds. In case of 
both dry and wet scaffolds the three highest compressive modulus values were measured 
from CS containing scaffolds. Two scaffold groups with the lowest compressive modulus 
contained COL and HA. Both wet and dry scaffolds recovered well from compression. 
This thesis demonstrated successful incorporation of CS and/or HA to COL in order 
to fabricate a highly porous freeze-dried 3D scaffold applicable for cartilage TE. In addi-
tion, the novel crosslinker GP proved to be a promising alternative to the conventional 
EDC/NHS crosslinker.  
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ABBREVIATIONS 
 
2D Two-dimensional 
3D Three-dimensional 
dH2O Distilled water 
D2O Heavy water 
ADH Adipic dihydrazide 
AFM Atomic force microscopy 
BP Benzophenone 
BSA Bovine serum albumin 
CAD Computer aided design 
CDI 1,1-carbonyldiimidazole 
Chi Chitosan 
CL Cross-linking 
CLer Crosslinker 
COL1 or COL2 Collagen type I or II 
CS Chondroitin sulfate 
CS-A or C4S Chondroitin sulfate type A or chondroitin-4-sulfate 
CS-C or C6S Chondroitin sulfate type C or chondroitin-6-sulfate 
CS-E or C4,6S Chondroitin sulfate type E or chondroitin-4,6-sulfate 
CSMA Chondroitin sulfate methacrylic anhydride 
DCS Differential scanning calorimetry 
DHT Dehydrothermal 
DIW Deionized water 
DMEM  Dulbecco's modified Eagle's medium  
DPBS   Dulbecco's PBS (see PBS) 
ECM Extracellular matrix 
EDC 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide  
hydrochloride 
EDGE Ethylene glycol diglycidyl ether 
ELN Elastin 
FD Filter dried   
GA Glutaraldehyde 
GAG Glycosaminoglycan 
Gel Gelatin 
GlcNAc  N-acetylglucosamine  
GMHA Glycidyl methacrylate-modifed hyaluronic acid 
GP Genipin 
GTA Glutaraldehyde 
HA Hyaluronic acid 
HAMA Hyaluronic acid methacrylic anhydride 
HCl Hydrocloric acid 
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IPN Interpenetrating polymeric network 
(h)MSC (human) Mesenchymal stem cell 
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NSC Neural stem cell 
NHS N-hydroxysuccinimide 
OA Osteoarthritis 
PBS Phosphate buffered saline solution 
PEM Polyelectrolyte multilayer  
PIC Polyion complex 
PU Polyurethane 
RT Room temperature  
Td Denaturation temperature 
TE Tissue engineering or tissue engineered 
TEM Transmission electron microscopy 
TG Thermogravimetric analysis 
TIPS Thermally induced phase separation 
TPP Two photon polymerization 
SD Standard deviation 
(E)SEM (Environmental) Scanning electron microscopy 
SW Soaking wet 
WST Water soluble tetrazolium 
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DEFINITIONS 
 
Bioabsorbable Capable of being degraded or dissolved and subsequently 
metabolized within an organism.  
Biocompatibility The ability of a material to perform with an appropriate host 
response in a specific application, and the quality of not hav-
ing toxic or injurious effects on biological systems. 
Biodegradation Gradual breakdown of a material mediated by specific bio-
logical activity or a biological system. Series of processes by 
which living systems render chemicals less noxious to the 
environment. 
Biomaterial Synthetic, natural or modified natural material intended to be 
in contact and interact with the biological system in order to 
evaluate, treat, augment or replace any tissue, organ or func-
tion of the body. 
Biopolymer Any polymer that is used as a biomaterial. (see polymer) 
Biostability The ability of a material to maintain its physical and chemical 
integrity after implantation in living tissue. 
Blend A uniform combination of two or more materials. 
Buffer solution Solution whose pH value is not appreciably changed by ad-
ditions of acid or alkali. 
Chondrocyte Mature cartilage cell. 
Chondrogenesis A process by which cartilage tissue is formed. 
Chondrogenic Cartilage forming. 
Composite material Structural material made of two or more distinctly different 
materials, where each component contributes positively to 
the final properties. 
Cross-linking Formation of covalent side bonds between different chains in 
a polymer. 
Cross-linking agent Substance that is used as an initiator of the reaction that es-
tablishes cross-links between reactive sites in polymer 
chains. 
Cytotoxic Able to kill or damage cells. 
Degradation Deleterious change in the chemical structure, physical prop-
erties, or appearance of a material. 
Denaturation Destruction of the native conformation or state of a biologi-
cal molecule by heat, extremes of pH, heavy metal ions, cha-
otropic agents etc., resulting in loss of biological activity. 
Extracellular matrix Matrix of proteins and glycoproteins surrounding cells in 
some tissues; located or occurring outside the cell. 
Fibrous tissue Form of connective-tissue consisting mainly of bundles of 
white fibres. 
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Hydrolysis Chemical reaction of a compound with water. 
Hydrophopic Having an affinity for water. 
Hydrophilic Not readily absorbing or interacting with water. 
in vitro Literally, “in glass” or “test tube”, used to refer to processes 
that are carried outside the living body, usually in the labor-
atory.  
in vivo Within the living body.  
Osteogenic Bone forming. 
Porogen Any of a mass of particles (of a specified shape and size) used 
to make pores in molded structures used for tissue engineer-
ing (dissolved away after the structure has set). 
Scaffold A temporary supporting structure for growing cells and tis-
sues; also called synthetic extracellular matrix. 
Tissue engineering Application of principles and methods of engineering and life 
sciences to the design, construction, modification, growth 
and maintenance of living tissues. Creation of devices for the 
study, restoration, modification and assembly of functional 
tissues from native or synthetic sources. 
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NOTATIONS 
 
Table 1. Scaffold groups and their composition. 
Notations of the test 
scaffold groups 
Interpretation of the abbreviations 
C100E 1.0 wt.% (v/v) COL; plain collagen scaffold, 
EDC/NHS cross-linked 
C100G 1.0 wt.% (v/v) COL; plain collagen scaffold, genipin 
cross-linked 
C80HE 1.0 wt.% (v/v) COL + 1.0 wt.% (m/v) HA | 80:20 
wt.% (v/v); collagen-hyaluronic acid composite 
scaffold, EDC/NHS cross-linked 
C80HG 1.0 wt.% (v/v) COL + 1.0 wt.% (m/v) HA | 80:20 
wt.% (v/v); collagen-hyaluronic acid composite 
scaffold, genipin cross-linked 
C60HE 1.0 wt.% (v/v) COL + 1.0 wt.% (m/v) HA | 60:40 
wt.% (v/v); collagen-hyaluronic acid composite 
scaffold, EDC/NHS cross-linked 
C80CSE 1.0 wt.% (v/v) COL + 1.0 wt.% (m/v) CS | 80:20 
wt.% (v/v); collagen 
chondroitin sulfate composite scaffold, EDC/NHS 
cross-linked 
C80CSG 1.0 wt.% (v/v) COL + 1.0 wt.% (m/v) CS | 80:20 
wt.% (v/v); collagen-chondroitin sulfate composite 
scaffold, genipin cross-linked 
C60CSE 1.0 wt.% (v/v) COL + 1.0 wt.% (m/v) CS | 60:40 
wt.% (v/v); collagen-chondroitin sulfate composite 
scaffold, EDC/NHS cross-linked 
C80CS15HE 1.0 wt.% (v/v) COL + 1.0 wt.% (m/v) CS + 1.0 wt.% 
(m/v) HA | 80:15:5 wt.% (v/v); collagen-chondroitin 
sulfate-hyaluronic acid composite scaffold, 
EDC/NHS cross-linked 
C80CS15HG 1.0 wt.% (v/v) COL + 1.0 wt.% (m/v) CS + 1.0 wt.% 
(m/v) HA | 80:15:5 wt.% (v/v); collagen-chondroitin 
sulfate-hyaluronic acid composite scaffold, genipin 
cross-linked 
C60CS30HE 1.0 wt.% (v/v) COL + 1.0 wt.% (m/v) CS + 1.0 wt.% 
(m/v) HA | 60:30:10 wt.% (v/v); collagen-chon-
droitin sulfate-hyaluronic acid composite scaffold, 
EDC/NHS cross-linked 
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1 INTRODUCTION 
Cartilage reconstruction has become an important topic in modern medicine for both 
functional and esthetic surgery [104]. The need for treatments options is strongly associ-
ated with the fact that native cartilage is a hypocellular, avascular and not innervated 
tissue and thus heals poorly [133]. Osteoarthritis (OA) is a common joint disorder that 
progressively leads to the loss of cartilage. In addition, injuries to the articular cartilage 
tissue can occur through various mechanisms. Most common injury is a blunt trauma 
(caused by e.g. a car accident or a fall from a height) that breaks piece of cartilage from 
the end of the bone. [28] After such traumas, articular cartilage often remains unhealed 
due to incomplete bonding of the fractured surfaces [27]. Since current clinical methods 
have limited ability to regenerate functional cartilage [111], especially OA has become a 
major socio-economic burden [66]. In recent years, the cartilage repair-related research 
has focused on tissue engineering solutions that provide templates (scaffolds) to fill the 
tissue lesion, and ultimately form new cartilage [130].  
Scaffolds intended for cartilage regeneration have many requirements, including ad-
equate nutrient and waste transport, adhesion to the defect site, minimally invasive im-
plantation or injection, biocompatibility and biodegradability [60]. A temporary three-
dimensional (3D) scaffold mimics the physiological properties and functions of the car-
tilage extracellular matrix (ECM) [111] enabling a microenvironment that can induce 
chondrocytes into appropriate differentiation and functional state under in vitro condi-
tions [64]. Furthermore, one of the most important criteria that ultimately leads to the 
success or failure of the scaffold is its ability to provide structural support during new 
tissue formation [111].  
In terms of choosing a suitable material for a cartilage scaffold, it is favorable to de-
sign a scaffold based on the natural cartilage composition. Cartilage matrix is a gel-like 
substance composed of water and the macromolecular polyanionic substances (proteo-
glycans and collagen). Proteoglycans are elastic molecules that expand in solution and 
strongly resist compression into a smaller volume. In the cartilage matrix, proteoglycans 
are arranged in high-molecular-weight aggregates formed by noncovalent association be-
tween proteoglycan subunits (hyaluronic acid and a linkage protein, collagen). Glycosa-
minoglycans, from which chondroitin sulfate is the prominent one, are attached to the 
collagen core or backbone. [84] Given the nature and composition of native cartilage, 
combination of collagen with chondroitin sulfate and/or hyaluronic acid have received a 
deserved and widespread interest in the field of cartilage tissue engineering [6]. In fact, 
modification of collagen scaffolds by chondroitin sulfate and hyaluronic acid has been 
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proposed to enhance chondrocyte differentiation into better cartilage and to provide the 
necessary molecules for cell attachment [64].  
The aim of this thesis was to fabricate and characterize porous freeze-dried 3D com-
posite scaffolds with different amounts (wt.%) of collagen I, chondroitin sulfate and hy-
aluronic acid that mimic the native cartilage composition. The scaffolds were evaluated 
in terms of applicability for cartilage reconstruction as well as keeping in mind the basic 
requirements of a porous 3D tissue engineering scaffold. The theoretical background 
gives an overview of the basic material properties of collagen, hyaluronic acid and chon-
droitin sulfate as well as their use in tissue engineering. It also provides basic information 
concerning the two cross-linking agents used in the present study; 1-ethyl-3-(3-dimethyl-
aminopropyl)-carbodiimide hydrochloride / N-hydroxysuccinimide (EDC/NHS) and 
genipin. Different processing methods for porous scaffold fabrication are also presented; 
focus being on freeze-drying, the method used for manufacturing the scaffolds in this 
work.  
The scaffolds were fabricated by freeze-drying and cross-linked with EDC/NHS or 
genipin. To study the effects between EDC/NHS and genipin cross-linking as well as the 
different collagen, hyaluronic acid and/or chondroitin sulfate compositions, the compres-
sion properties, recovery from compression, water uptake and swelling of the scaffolds 
were investigated. The compressive modulus and compressive stiffness values were de-
termined separately for dry and wet scaffolds. The water uptake and swelling abilities of 
the scaffolds were evaluated after immersion in PBS (37ºC) for 24 hours. The dimensional 
changes of the scaffolds were investigated in connection with water uptake and compres-
sion (i.e. recovery after the compression) tests. Fourier transform infrared (FTIR) spec-
troscopy was used to analyze the cross-linking treatments and micro-computer tomogra-
phy (micro-CT) imaging to study the microstructure of the scaffolds. 
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2 BIOABSORBABLE NATURAL POLYMERS 
2.1 Collagen 
Collagen is a ubiquitous protein in mammalian tissues, accounting around 20-30% of total 
body proteins [72]. For most soft and hard connective tissues, collagen fibrils and their 
networks function as the ECM (i.e. highly organized, 3D architecture surrounding various 
cells) [12]. It prevails in the ECM of skin, cartilage, bone, tendon and ligaments and forms 
the structural framework of tissues like cornea and blood vessels [68]. Fibroblasts are 
responsible for the production of most collagens in connective tissue [104]. 
The basic unit of collagen is a polypeptide composed of repeating sequence of three 
amino acids: glycine, proline and hydroxyproline [68]. There exists over 20 genetically 
different collagen molecules with varying abundance, functionality and distributions in 
tissues [141]. The most abundant and widespread group of collagens are the fibril-form-
ing collagens (types I, II, III, V, XI), which comprise about 90% of the total collagen 
content in tissues [32]. Their distinctive feature is high tensile strength [33]. Different 
collagen types are listed in Table 2.1 according to their family and tissue distribution. For 
instance, bone tissues are mainly constructed from type I and V collagens that form a 
framework anchoring nano-sized hydroxyapatite crystals. In cartilage type II collagen is 
the main component, accounting approximately 60% of the dry weight of the tissue. Other 
collagen types found in cartilage are VI, IX and XI collagens and even trace amounts of 
type I collagen can be detected in it. Type II, IX, and XI collagens form a fibrillar network 
that gives the cartilage tissue tensile stiffness and strength. Type VI collagen forms part 
of the cartilage matrix that immediately surrounds the chondrocytes and may help the 
chondrocytes to attach to the macromolecular framework of the matrix. [8]  
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Table 2.1. Various collagen types divided into individual families according to their dis-
tinctive features and tissue distribution. Modified from [32]. 
Family and type Tissue distribution 
Fibril-forming collagens  
I bone, dermis, tendon, ligaments, cornea 
II cartilage, vitreous body, nucleus pulposus 
III skin, vessel wall, reticular fibers in most tissues 
(lungs, liver, spleen etc.) 
V lung, cornea, bone, fetal membranes; together with 
type I collagen 
XI cartilage, vitreous body 
Basement membrane collagens  
IV basement membranes 
Microfibrillar collagens  
VI widespread: dermis, cartilage, placenta, lungs, ves-
sel wall, intervertebral disc 
Anchoring fibrils  
VII skin, dermal– epidermal junctions; oral mucosa, 
cervix 
Hexagonal network-forming col-
lagens 
 
VIII endothelial cells, Descemet’s membrane 
X hypertrophic cartilage 
FACIT collagens  
IX cartilage, vitreous humor, cornea 
XII perichondrium, ligaments, tendon 
XIV dermis, tendon, vessel wall, placenta, lungs, liver 
XIX human rhabdomyosarcoma 
XX corneal epithelium, embryonic skin, sternal carti-
lage, tendon 
XXI blood vessel wall 
Transmembrane collagens  
XIII epidermis, hair follicle, endomysium, intestine, 
chondrocytes, lungs, liver 
XVII dermal-epidermal junctions 
Multiplexins  
XV fibroblasts, smooth muscle cells, kidney, pancreas 
XVI fibroblasts, amnion, keratinocytes 
XVIII lungs, liver 
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Despite the vast diversity of structurally different collagen molecules, all members have 
one common characteristic feature: three left-handed polypeptide α-chains wrapped 
around each other forming a right-handed triple helix (procollagen) [32, 72]. A procolla-
gen peptidase removes loose termini to create a tropocollagen molecule. Tropocollagen 
molecules then self-assemble to microfibrils that further bundle up as collagen fibrils. 
These growing fibrils finally self-assemble to form a collagen fiber. [38] Each collagen 
molecules has a molecular weight of approximately 300 kiloDaltons [72] and each indi-
vidual polypeptide chain of collagen contains approximately 1000 amino acid residues 
[92]. The pre-described process of the collagen assembly is shown in Figure 2.1 (a). Fig-
ure 2.1 (b) illustrates the collagen structure from a tropocollagen helix to the form of a 
collagen fiber.  
 
           
(a)        (b) 
 
Figure 2.1. The collagen self-assembly (a) and the structure of collagen from tropocol-
lagen to a collagen fiber (b). Modified from [121, 38]. 
 
There are approximately 25 different α-chain conformations, each of which is produced 
by their unique gene [104]. The triple helix structure is important to the nature of collagen, 
since it protects its integrity against proteases and plays an important role in cell adhesion 
and the assembly of the ECM [20]. Additionally, the ability of the polypeptide strands to 
self-aggregate enables stable fibers formation in the physiological condition and thus pro-
vides mechanical support [147].  
Collagen has numerous structural and functional roles depending on the tissue where 
it is located in. It induces important events in the cell microenvironment and is involved 
in the storage and release of cell mediators, such as growth factors. [33] Cell-matrix in-
teractions are induced mostly by the interaction of cells with collagen, either directly or 
indirectly. Direct cell-collagen interactions imply cell receptors that recognize specific 
peptide sequence located within the collagen molecule. The indirect interactions between 
cells and collagen are normally the ones that achieve stable adhesion of cell to the ECM. 
[104] The ability to withstand tensile loads is directly related to the fibrous nature [68] 
and the intramolecular crosslinks of collagen [46]. Collagen plays a dominant role in 
maintaining the biologic and structural integrity of vertebrates and other organisms [33, 
12]. It is highly dynamic molecule that undergoes constant remodeling for proper physi-
ologic functions [12].  
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2.2  Hyaluronic acid 
Hyaluronic acid (also known as hyaluronan or hyaluronate [120]) is a highly hydrophilic 
polysaccharide [30] and a major intracellular component of connective tissues [19]. It was 
first discovered and isolated in 1934 from the vitreous body of the eye. However, it was 
not until 20 years later that its structure was completely determined. [39] Hyaluronic acid 
is a non-sulfated linear polymer that is homogenous in its primary structure [29]. It is 
composed of repeating disaccharide units, ß-1,4-D-glucuronic acid and ß-1,3-N-acetyl-
D-glucosamine (Figure 2.2). Hyaluronic acid is chemically classified to the family of 
glycosaminoglycans (GAGs). [39] It is considerably larger compared to the other GAGs 
[29] with a molecular weight of 1000-104 kiloDaltons [30]. Hyaluronic acid is widely 
distributed component in the ECM of vertebrate’s tissues. Its pronounced viscoelastic 
properties and the biophysical basis (related to its ‘non-ideal’ behavior) have made hya-
luronic acid a source of great interest and speculation. [39] 
 
 
Figure 2.2. Chemical structure of hyaluronic acid. [97] 
 
After the early work of researchers Laurent (1955) and Balazs (1970), it was concluded 
that hyaluronic acid chains behave as a stiffened random coil in solution. In recent years 
this relative simple model has been challenged by proposing that hyaluronic acid chains 
self-associate, and thereby dominate the solution properties. The abundant data found in 
the current literature suggests that hyaluronic acid chains do not strongly self-associate in 
aqueous solution, but their self-association might be very weak and transient and contrib-
ute to the so-called ‘non-ideal’ behavior. Today, based on the bulk solution properties 
hyaluronic acid is in fact best described as a random coil with considerable internal stiff-
ness; attributed to direct or water-mediated intramolecular hydrogen-bonding pattern 
across the glycosidic linkages. The conformation of the individual saccharide units in 
hyaluronic acid is an important factor that contributes to the overall shape of the molecule. 
Both glucuronic acid and the N-acetylglucosamine moieties appear to exits mainly in 
chair forms, which limits the flexibility of the molecule. However, the conformation of 
hyaluronic acid has been shown to vary due to the binding of proteins. [39]  
Since its initial isolation, the physical properties of hyaluronic acid have been the 
dominant feature that distinguish it from other ECM components. In addition to not being 
covalently bound to proteins of any tissue, hyaluronic acid is the only non-sulfated GAG. 
However, specific hyaluronic acid-protein interactions have been shown; foremost the 
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association with CD44 antigen (a cell-surface glycoprotein). [39] Hyaluronic acid is an 
important component of native ECM and most tissues including synovial fluids of joints, 
skin and articular cartilage [6, 98]. This ubiquitous polyanion is also responsible for sev-
eral structural and biological properties that mediate cellular signaling, cell growth and 
differentiation, morphogenesis and matrix organization [109]. In addition, hyaluronic 
acid has an essential role in wound repair [109], in controlling tissue permeation and hy-
dration, in macromolecular transport between cells and in bacterial invasiveness [39]. 
While numerous investigations have focused on the extracellular roles of hyaluronic acid, 
there is a growing interest towards its putative intracellular roles. Hyaluronic acid has 
been suggested to contribute in cell cycle. It may also modulate the trafficking of specific 
kinases in the cell and thereby regulate cell behavior. [39] 
Hyaluronic acid plays an important role in regulating the water and electrolyte balance 
of tissues [113]. Compared to other ECM molecules, hyaluronic acid has unique hygro-
scopic, rheological and viscoelastic properties. When not bound to other molecules, it has 
the ability to self-associate into 3D structures in solutions and bind up to 1000 times its 
weight in water, which gives it a stiff viscous quality similar to gel-like gelatin [49, 97, 
30]. The hydrophilic nature of hyaluronic acid creates an environment permissive for mi-
gration of cells to new tissue sites, while its free-radical scavenging and protein exclusion 
properties offer protection to cells and ECM molecules against free-radical and proteo-
lytic damage [6]. Other unique properties of hyaluronic acid are its ability to promote 
angiogenesis and modulate wound site inflammation. It is recognized by receptors on a 
number of different cells associated with tissue repair. It promotes mesenchymal and ep-
ithelial cell migration and differentiation, and thereby enhances collagen deposition 
alongside with angiogenesis. [97] 
2.3 Chondroitin sulfate 
Chondroitin sulfate (also known as chondroitin, chonsurid or chondroitin sulfuric acid 
[15]) is another representative of the GAG family. The natural abundance and wide dis-
tribution of chondroitin sulfate in all living creatures apart from plants reflect its central 
role in biological processes. [70] Chondroitin sulfate is the prevalent GAG in the articular 
cartilage [97], varying from 20 to 80% of its total GAG content [147]. Structurally this 
linear polymer comprises of repeating disaccharide units of D-glucuronic acid and N-
acetyl-D-galactosamine (GalNac) with a molecular weight of 50-100 kiloDaltons [9, 54]. 
Other than containing 25-30 such units in the average chain, chondroitin sulfate does not 
have a uniform structure. Naturally occurring modifications of chondroitin are a result of 
varying sulfate residue distribution along the chains. The classification and type of chon-
droitin sulfate is determined by the sulfate group placing: most commonly located in car-
bon 4 (CS-A or C4S), carbon 6 (CS-C or C6S) or in both 4 and 6 carbons (CS-E or C4, 
6S). [139] CS-B is no longer classified as a form of chondroitin sulfate, since it later 
turned out to be a fellow GAG called dermatan sulfate [91]. The changes in terminology 
with time are due to the fact that chondroitin sulfate was originally isolated well before 
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its structure was characterized. Early scientists used letters as nomenclature. [76] Later 
also numbers have been used to indicate the sulfate group including carbon unit [91]. The 
different types of chondroitin sulfate are presented in Table 2.2.  
 
Table 2.2. Different types of chondroitin sulfate and their nomenclature. Modified from 
[91]. 
Letter 
identification 
Site of sulfation Systematic name Number 
identification 
CS-A carbon 4 of the GalNAc 
sugar 
chondroitin-4-sulfate C4S 
CS-C carbon 6 of the GalNAc 
sugar 
chondroitin-6-sulfate C6S 
CS-D carbon 2 of the glucuronic 
acid and 6 of the GalNAc 
sugar 
chondroitin-2,6-
sulfate 
C2,6S 
CS-E carbons 4 and 6 of the 
GalNAc sugar 
chondroitin-4,6-
sulfate 
C4,6S 
 
Most abundant variations of chondroitin sulfate found in the joint tissue are C4S and C6S 
[66]. Their chemical structures are shown in Figure 2.3.  
 
(a)    (b)  
 
Figure 2.3. Chemical structure of (a) chondroitin 4-sulphate and (b) chondroitin 6-sul-
phate [23]. 
 
The composition and concentration of chondroitin sulfate depends on the function of the 
relevant organism and tissue [93]. It is found mostly in large aggregating proteoglycans 
(PGs) with 20-100 GAG chains of 15-70 kiloDaltons [29]. Chondroitin sulfate is a major 
component in the ECM of connective tissue [62]. It is present both in cancellous and 
compact bones [115], tendon and ligaments [79]. But more importantly, chondroitin sul-
fate is the key constituent of aggrecan (cartilage-specific proteoglycan protein) [62], 
shown in Figure 2.4. Chondroitin sulfate plays an important role in cartilage by regulating 
the expression of the chondrocyte phenotype and stimulating the metabolic response of 
cartilage tissue. Most importantly, chondroitin sulfate plays a major role in creating os-
motic pressure that expands the matrix and places the collagen network under tension. 
This creates water-trapping system of PGs that absorbs compression while moving. [62] 
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This is explained more specifically in the next paragraph alongside with the structure of 
native cartilage (Figure 2.4).  
Cartilage matrix is a gel-like substance. Its abundant ECM surrounds chondrocytes 
and is composed of water and the macromolecular polyanionic substances, i.e. PGs and 
collagen. [79] Collagen fibrils form the framework of articular cartilage and help it to 
resist tensile stress [93]. PGs consist of a protein core or backbone that has side chains of 
chondroitin and keratin sulfate attached to it. Because of their repelling negative charges, 
chondroitin sulfate side chains are attached to a protein core at nearly right angles [79]. 
In the cartilage matrix PGs are arranged in high-molecular-weight aggrecans formed by 
noncovalent association between PG subunits, hyaluronic acid and linkage protein. PGs 
are elastic molecules that expand in solution exerting a swelling pressure to the tissue. 
[79] They strongly resist compression into a smaller volume by being constantly re-
strained by the collagen network in which they are entrapped [93, 79]. Small PGs, such 
as decorin, biglycan and fibromodulin, bind to other matrix macromolecules and thereby 
help to stabilize the matrix. They may also bind growth factors and influence the function 
of the chondrocytes. [8] Together the collagen framework and the PGs give the cartilage 
matrix its unique load-bearing properties [70]. Figure 2.4 shows an illustrative presenta-
tion of the cartilage matrix.  
 
 
Figure 2.4. Schematic presentation of cartilage structure. Modified from [66]. 
 
Chondroitin sulfate was first identified as a component of cartilage in 1940, and since the 
1980s its effectiveness has been continuously investigated. [133] The best described func-
tion is its structural role within cartilage [70]. In cartilage, multiple chondroitin sulfate 
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including aggrecan molecules bind to hyaluronic acid via a protein link and form large 
aggregated proteoglycans (PGs) that carry a negative charge and therefore attract cations. 
This phenomenon increases the osmolality, which in turn draws water into the ECM re-
sulting in resistance towards compression stress. [133] Chondroitin sulfate helps to main-
tain healthy cartilage by absorbing fluid (particularly water) into the connective tissue. 
Supposedly it also blocks enzymes that break down cartilage and provides the building 
blocks for the body to produce new cartilage. [15]  
Other than its roles within cartilage, chondroitin sulfate has important biological func-
tions in the development of brain [145]. It possess anti-inflammatory activity [54] and is 
known to involve in intracellular signaling, cell recognition and connecting ECM com-
ponents to cell-surface glycoproteins. Furthermore, chondroitin sulfate has been reported 
to involve in a process of long bone growth (endochondral ossification). [62] 
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3 THE USE OF NATURAL POLYMERS IN TIS-
SUE ENGINEERING 
After a century of developing synthetic polymers, scientists are turning back towards the 
usage of natural polymers [60]. In general, the use of natural polymers for tissue engi-
neering applications is a beneficial choice due to their excellent biocompatibility and be-
cause their structures mimic closely native cellular environments. Moreover, natural pol-
ymers have unique mechanical properties, and are biodegraded by an enzymatic or hy-
drolytic mechanism. [98] For cartilage tissue engineering natural biomaterials are com-
monly used due to their abundant availability because they possess many intrinsic pro-
chondrogenic properties and are commonly involved in native cellular processes [60]. 
Hyaluronic acid and chondroitin sulfate are the most valued GAGs in the market because 
of their prevalence in mammalian tissues, beneficial biological and physiological func-
tions such as high bioactivity [139].  
The wide distribution in nature, natural biocompatibility and biodegradation make 
their use as biomaterials beneficial as well as practical. However, while some of the char-
acteristics of natural polymers are considered as remarkable advantages, some of them 
may also restrict their use. In most cases, poor mechanical strength and relatively fast 
degradation constrain natural biomaterial design. Usually these problems are overcome 
by different cross-linking treatments, combining mechanically stronger materials with 
weaker ones, adding fibers to the structure etc. [33] The following chapters give insight 
into the applications of collagen, hyaluronic acid and chondroitin sulfate in tissue engi-
neering, as individual biomaterials as well as composite scaffolds. Given the nature and 
composition of the ECM architecture of native cartilage, together collagen, hyaluronic 
acid and chondroitin sulfate could well be a promising composite material designed es-
pecially for cartilage tissue engineering purposes. 
3.1 Collagen in tissue engineering 
Collagens, the oldest and most well understood class of biomaterials [141] have shown 
superior advantages not only as a scaffold material in tissue engineering, but also as a 
coating material for implants [23]. Its well-understood structure, low antigenicity and re-
markable biochemical and physical properties have made it widely used biomaterial in a 
variety of applications [141, 72] from injectable collagen matrices to bone regeneration 
scaffolds [104]. Scientific investigations involving collagen have inspired tissue engi-
neering, since collagen fibrils and their networks primarily regulate and define most tis-
sues. The collagen networks form a highly organized 3D architecture that entraps other 
ingredients. [12]  
The tissue engineering applications exploiting collagen as a biomaterial have been 
intensively growing in the past decades. The fact that it is easily available and highly 
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versatile makes it an attractive choice. Major advantages of collagen as a biomaterial in-
clude its synergy with bioactive components, easy modifiability and abilities to promote 
blood coagulation. Collagen can be processed into numerous different structures and 
shapes such as sponges, fibers, films, 3D gels, fleeces and beads without harming the 
basic molecule structure. In tissue engineering it has been used for skin replacement, bone 
substitutes and artificial blood vessels and valves. [72] Collagen is a naturally occurring 
abundant protein within native cartilage, where it induces intrinsic cell-binding motifs 
and enzyme-specific degradation [60]. Fibril-forming collagens are the most commonly 
used in the production of collagen-based biomaterials, from which type I collagen is cur-
rently the gold standard in the field of tissue engineering [104].  
Collagen possesses also some major disadvantages that limit or complicate more or 
less its clinical use. Collagen has relatively weak mechanical endurance and thermal sta-
bility, due to its protein nature [46, 33]. In addition, all collagens are very soft and can 
contract during culture [60], which makes it difficult to sterilize them without altering 
their structure [104]. Isolated collagens have various cross-link densities, fiber sizes, trace 
impurities etc. and in addition they bear the risk of viral infection such as bovine spongi-
form encephalopathy (BSE) [33, 72]. The hydrophilicity of collagen does not only lead 
to e.g. swelling and rapid release of incorporated drugs but results also in its fast degra-
dation [72]. In some cases the use of biological materials for medical applications can 
trigger an immune response in patients. Type I collagen has, nonetheless been regarded 
as a suitable material for implantation, since only a small amount of people possess hu-
moral immunity against it and a simple allergic test can verify patient’s response to the 
biomaterials based on this type of collagen. [104]  
Collagen, being the most abundant proteins on earth can be extracted from almost 
every living animal [104]. Desired collagens can be isolated from tissues that are rich in 
the relevant collagen type. An extraction of isolated collagen triple helices has been re-
ferred to as ‘‘monomeric’’, whereas extracted collagen with a retained fibrillar structure 
have been referred to as ‘‘polymeric’’. [128] Currently the majority of industrial collagens 
are extracted from animal derivatives such as porcine, calf and bovine skin, bovine tendon 
and rat tail [72]. 
Collagen constitutes over 30% of total body proteins of mammalian tissues, which 
makes it abundant and easily purified from living organisms [72]. However, animal-de-
rived collagen raises concerns over the possible transmission of infectious agents. There-
fore complementary alternatives, such as recombinant collagens are also used and stud-
ied. Compared to animal-derived collagens, the recombinant sources of human collagen 
(rhC) provide more reliable, predictable and chemically defined source of collagens. [33] 
Today, in addition to animal-derived collagens, the recombinant collagens are acknowl-
edged as one of the most useful biomaterials available and currently widely used in the 
field of tissue engineering, cosmetic surgery and drug delivery systems [12]. For example, 
a company called Fibrogen® have been distributing recombinant human collagen since 
2004. Their product is marketed potentially less immunogenic than animal sources and 
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their different production lots identical in composition. Products like this may well be 
paving the way for the future of collagen scaffolds. [104]  
Another area of research is the development of artificial collagen-like materials. As 
an example, Paramonov et al. [103] have prepared collagenous peptide polymers using 
native chemical ligation techniques; more precisely by a solid phase peptide synthesis, 
polymerization and self-assembly. Their product is presented as a mesh of nanofibers that 
resembles natural collagen fibrils by maintaining the characteristic circular dichroism sig-
nal for collagen triple helices. [103] 
3.2 Hyaluronic acid in tissue engineering 
Hyaluronic acid and its derivatives (both in solution and hydrogel form have) shown a 
great promise as a biomaterial in many medical products for over three decades [9]. Its 
ability to maintain hydrated environment is ideal for cell infiltration [19]. Applications 
range from various areas of tissue culture scaffolds to cosmetic surgery [109]. Soluble 
hyaluronic acid has been used in ocular surgery, viscosupplementation for arthritis and 
wound repair. However, its poor mechanical properties and rapid degradation in vivo hin-
der its direct clinical use. [26] 
For the past decade hyaluronic acid has been used as an important building block for 
the creation of new biomaterials for the use in cell therapy and 3D tissue culture scaffolds 
[109]. Its abilities to act as a space filler and a lubricant for movable parts of the body, 
makes hyaluronic acid one of the most beneficial research subjects particularly in the 
fields of orthopedics [49]. Furthermore, hyaluronic acid is known to bind to specific pro-
teins called hyaladherins, found in the ECM and on the cell surface, which stabilize es-
pecially the cartilage matrix and mediate cell adhesion and motility, cellular proliferation, 
cancer metastasis and inflammation [110, 118].  
The fact that hyaluronic acid enhances collagen deposition and angiogenesis by pro-
moting mesenchymal epithelial cell migration and differentiation, in addition to its im-
munoneutrality, makes it an ideal biomaterial for tissue engineering and drug delivery 
applications. Also, its water solubility allows hyaluronic acid to be fabricated into various 
types of porous and 3D structures. [97] However, its water solubility and fast resorption 
also preclude its use in many medical applications [33]. For particular tissue engineering 
purposes, hyaluronic acid is too weak and fluid as a homopolymer to create a supportive 
scaffold [134]. It needs to be hydrophobically modified or chemically cross-linked to gain 
better chemical and mechanical stability [118]. Due to the high functionality and charge 
density of hyaluronic acid, it can be cross-linked with a variety of chemical and physical 
methods [97]. Chemical modifications of hyaluronic acid target three functional groups: 
the glucuronic acid carboxylic acid, the primary and secondary hydroxyl groups and the 
N-acetyl group [6]. Chemically modified HA can be transformed into numerous physical 
forms without loss of biocompatibility [6] and has been proven to reduce significantly the 
degradation rate of the polymer [97]. These forms include viscoelastic solutions, soft or 
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stiff hydrogels, nanoparticulate fluids, electrospun fibers, non-woven meshes, powder, 
macroporous and fibrillar sponges, flexible sheets and films [9]. 
Hyaluronic acid has been studied and used extensively as a hydrogel in numerous 
biomedical applications. In many occasions hyaluronic acid hydrogel is designed for en-
capsulation and delivery of cells, drugs or molecules like growth factors and DNA. Sim-
ilar designs have also been exploited to produce tumor models, where cancer cells are 
encapsulated and injected in vivo; introducing a “tumor engineering” strategy for creation 
of orthopedic xenografts. Various modifications of hyaluronic acid enable the fabrication 
of stable and enzymatically degradable hydrogels, including aldehyde-modified hyalu-
ronic acid, tyramine-modified hyaluronic acid, dihydrazide-modified hyaluronic acid etc. 
[9] In one study the researchers fabricated collagen-hyaluronic acid composite hydrogels 
for DNA delivery by cross-linking hyaluronic acid with poly(ethylene glycol) diglycidyl 
ether [116]. Moreover, hyaluronic acid-based materials have replaced collagen-based ma-
terials as the standard soft tissue filler [28]. 
Hyaluronic acid can be extracted from natural mammalian sources of vitreous body, 
synovial fluid, umbilical cord and rooster comb [111]. Marine wastes have also been ex-
plored in search of new sources of hyaluronic acid. So far it has been found in the vitreous 
humor of various fish species and in cartilage of chondrichthyes. [139] Other sources for 
extraction have been certain strains of streptococci [71]. Since 2007 the usage of biopro-
cess methods for hyaluronic acid synthesis has gained interest and in 2011 the first ani-
mal-free (recombinant) hyaluronate was synthesized with Bacillius subtilis by a company 
called Novozymes [97, 134]. Since 2012 hyaluronic acid has been extracted from Strep-
tococci bacteria through fermentation to eliminate the possibility of transferring inter-
species diseases. The production of hyaluronic acid through fermentation has gradually 
been replacing the hyaluronic acid obtained from animal origin. [19] In terms of microbial 
production of hyaluronic acid, several culture variables have been studied and optimized. 
These include e.g. lysozyme or hyaluronidase addition, agitation and aeration conditions, 
the type of bioreactor, effect of pH-gradient stress, continuous culture, medium optimi-
zation and fed-batch operation. [139] 
3.3 Chondroitin sulfate in tissue engineering 
Chondroitin sulfate is another human carbohydrate that has shown promise as a nontoxic 
and biocompatible biomaterial [134, 56]. Scientists have been particularly interested in 
its anti-inflammatory properties, ability to reduce pain and improve articular functions 
[54]. Chondroitin sulfate has also been widely used to treat OA by oral dosing [62]. In 
some studies, chondroitin supplements have shown to decrease the pain associated with 
OA. However, not all studies are positive. In fact, several of them have not shown any 
beneficial effect from taking chondroitin. It is not clear, why the studies have different 
results, and therefore experts disagree on whether chondroitin is indeed helpful in treating 
OA or not. [135] Other applications include its use against psoriasis and atherosclerosis 
[54], bladder conditions [135] and high cholesterol [62]. It has also been suggested to 
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affect positively on Alzheimer’s disease, heart disease and weak bones (osteoporosis). 
However, so far there have not been any studies to evaluate these claims. [135]  
Chondroitin sulfate can also be found in cosmetics, eye drops and creams [70] and it 
can be used as dietary supplements; most of them made from cow cartilage. As an exam-
ple of a commercialized dietary supplement is BioCell Collagen®, where chondroitin sul-
fate is mixed together with collagen and hyaluronic acid. It provides nutrients essential 
for maintaining cartilage, tendon and ligament connective tissue health, and has clinically 
shown to improve joint comfort and mobility. [6] The central role of chondroitin sulfate 
in natural wound healing and chondrogenesis has made it also a subject of extensive re-
search as a hydrogel for wound dressings and cartilage tissue engineering scaffolds [134]. 
The number of commercial applications of chondroitin sulfate has continuously been 
increased due to its high biocompatibility [139] and its central role in natural wound heal-
ing and chondrogenesis [134]. Similar to hyaluronic acid, several chemical and physical 
cross-linking techniques have been developed for chondroitin sulfate to form hydrogels 
for biomedical applications [97]. When included in hydrogels, chondroitin sulfate partic-
ipates in re-epithelialization, stimulation of neovascularization and supply of growth fac-
tors and cytokines. Its combination with other biopolymers, such as collagen, PGs and 
hyaluronic acid in order to formulate scaffolds with slow and controlled biodegradability 
that promote and accelerate the regeneration of damaged structures has been studied 
mainly in the engineering of biological tissues associated with the processes of bone re-
pair, cartilage and cutaneous wound. [139] 
Many studies have reported chondroitin sulfate having the ability to stimulate and 
promote significantly the bioactivity of seeded chondrocytes [97]. In vitro studies suggest 
that chondroitin sulfate can impact processes associated with cartilage degeneration by 
promoting synthesis of proteoglycans, which are lost during cartilage degeneration, re-
ducing gene expression for a range of proteolytic enzymes and reducing subchondral bone 
resorption in combination with glucosamine [70]. Recent studies have demonstrated that 
CS-E is a potent antiviral, whereas chondroitin sulfate-PG is a potential target for the 
development of vaccines against malaria. In addition, there have been reports of new find-
ings concerning the sulfation pattern of chondroitin sulfate and its relation to cancer cell 
mechanisms. [139] 
Currently the route of chondroitin sulfate administration is oral and the most success-
ful commercial products of chondroitin sulfate by market volume still remain associated 
with OA. The effectiveness of chondroitin sulfate for the treatment of OA has been evi-
dent through three main mechanisms: 1) stimulation of ECM production by chondrocytes; 
2) suppression of inflammatory mediators; and 3) inhibition of cartilage degeneration. 
[66] In the field of cartilage tissue engineering many researches aim to discover, whether 
tissue engineering scaffolds can provide similar advantages. An example of exploiting 
the bioactive abilities of chondroitin sulfate for a tissue engineering application is a study 
by Kangjian et al. [56], in which they created a collagen-chitosan-chondroitin sulfate 
scaffold. Chondroitin sulfate was added to the composite construct in order to provide the 
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biological activity of polysaccharides and to further improve scaffold’s stability and bio-
compatibility [56].  
Chondroitin sulfate has also shown promise in bone tissue engineering. Schneiders et 
al. [114] demonstrated in their study that the addition of chondroitin sulfate to hyaluronic 
acid/collagen composites enhances bone remodeling and new bone formation. Chon-
droitin has shown to influence directly on the osteogenetic differentiation of human mes-
enchymal stem cells (MSC) and osteogenesis in vivo through functional groups (sulphate, 
carboxyl) that interact with mineral components of bone such as hydroxyapatite. This 
makes the addition of chondroitin sulfate to bone substitutes an attractive choice in order 
to increase their osteoconductive properties. [115]  
There are several reported sources for the isolation of chondroitin sulfate. Commercial 
chondroitin sulfate can be extracted from mammalian derivatives such as nasal and tra-
chea from bovine and swine. [139] Other natural sources from chondroitin are marine 
substrates from shark cartilage [70], ray [139] and sea cucumber [62]. Chondroitin sulfate 
derived from fish is as a better source than mammalian because of its sulfation pattern 
and safety [139]. The source organism and tissue, location within a tissue as well as age 
affect chondroitin sulfate structure, which in turn affects its function in vivo. The different 
molecular functions of chondroitin sulfate offer potential for different therapeutic im-
pacts. Clinical studies of commercial chondroitin have all confirmed the safety of chon-
droitin sulfate as a nontoxic and biocompatible biomaterial, regardless of its origin. [70, 
66] Nevertheless, due to concerns over the BSE disease and other food chain crisis, search 
for other alternative sources for the isolation of chondroitin sulfate continues. The explo-
ration of micro-organisms and marine organisms as a source material has received in-
creasing attention. [139]  
The types of applications for the formulations of chondroitin sulfate or its derivatives, 
and thus their market price are dependent on the concentration and purity of this GAG in 
the commercial products. Different compounds, including chemical solvents and deter-
gents from the isolation step as well as peptides, proteins, nucleic acids or organic com-
pounds from tissues commonly contaminate the scaffolds and therefore reduce its com-
mercial value and limit its usage areas. Clinical applications demand highly concentrated 
and pure chondroitin sulfate compared to cosmetic, dietary supplements or other food 
ingredients. In general, the methods for the isolation of chondroitin sulfate from cartilage 
include following steps (defined during several years): (1) chemical hydrolysis of carti-
lage; (2) breakdown of proteoglycan core; (3) elimination of proteins and chondroitin 
sulfate recovery; and (4) purification of chondroitin. [139] 
In order to avoid the health and ecological problems caused by the use of mammalian 
and fishery wastes as a substrate, different approximations to microbial production of 
chondroitin sulfate-like polymers have been reported in recent years. Initially, Pasteurella 
multocida was one of the bacteria selected as a chondroitin sulfate producer, but its well-
known cholera pathogenicity has hindered and reduced its interest. Excellent results have 
been obtained in the production of capsular polysaccharide chondroitin sulfate precursor 
(CS-C) by Escherichia coli. However, E. coli is a low virulent pathogen, which limits its 
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large scale production. Moreover, CS-C is a non-sulfated structure of chondroitin (CS-O) 
with a furanose residue of fructose, which needs a subsequent step of chemical sulfation 
and hydrolysis of the fructose monomer. Nevertheless, chondroitin sulfate production by 
combined fermentation and chemical developments is a reckoned complementary alter-
native. [139] 
3.4 Natural polymer based composite scaffolds 
The composition and properties of biomaterials used to produce a tissue engineering scaf-
fold significantly affect the regeneration of neo-tissues and influence the conditions of 
collagen engineering [12]. From a biological point of view the natural polymers are more 
desirable option to prepare a tissue engineering scaffolds than synthetic material because 
their properties are more similar to native ECM [70]. Furthermore, possible cytotoxic 
effects of the degradation products released from synthetic polymers are not an issue, 
when using naturally derived molecules [20]. Natural polymers are derived from renew-
able resources, namely from plants, animals and micro-organisms, which gives them the 
beneficial ability to be degraded by naturally occurring enzymes. In addition, they possess 
many functional groups (i.e. amino, carboxylic and hydroxyl groups) available for chem-
ical and enzymatic modification such as hydrolysis, oxidation, conjugation with other 
molecules, and cross-linking reactions. This makes an overwhelming variety of products 
with tailor-made chemistries and properties possible. Addition of protein materials may 
offer an additional advantage, since they are able to interact favorably with cells through 
specific recognition domains present in their structure. [33]  
Cartilage tissue has many unique characteristics that demand specialized features 
from a chondrogenic tissue engineering scaffold [133]. In terms of material design a de-
gradable bioactive polymer with proper mechanic properties can be regarded as a prom-
ising choice for cartilage regeneration [44]. Other facts that need to be taken into account, 
when designing a cartilage-regenerative scaffold are that the cartilage lacks of vascular 
supply and that the cartilage tissue has no innervation. [133] Somehow the scaffolds 
should be fabricated as such, which restrain angio- and neurogenesis after being cultured 
with cells in vitro and finally implanted in vivo. This is major challenge that has not yet 
been overcome. All in all, studies have shown that successful cartilage regeneration can 
be achieved through the use of a tissue engineered implant only if the seeded cells undergo 
normal proliferation and differentiation within the biodegradable scaffold alongside with 
the production of a new cartilage-specific ECM [97]. 
Tissue engineered scaffolds that combine collagen (COL) with GAGs were initially 
developed for the use in skin grafting, but after their composition was adapted for ortho-
pedic applications, results have demonstrated their strong ability to support both chon-
drogenesis and osteogenesis [20]. Currently chondroitin sulfate (CS) and hyaluronic acid 
(HA) are the most valued GAGs in market because of their abundance in mammalian 
tissues, their physiological functions and high activity [139]. During the past decade, 
combining HA and/or CS to COL has been the subject of several investigations. Many of 
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those studies show a strong correlation between the use of either two (COL+HA/CS) or 
all three (COL+HA+CS) polymers and their usefulness for cartilage tissue engineering 
[94, 147, 147 etc.; found in the Appendices 11-12]. Researchers have been experimenting 
on numerous different composite structures such as membranes, microspheres, gels, fi-
bers and porous 3D scaffolds.  
Tables presented in the Appendices 9-12 show some of the studies concerning the 
manufacture and characterization of COL+CS/HA/CS+HA scaffolds. The studies are 
listed from top to bottom according to their resemblance to the present study; i.e. freeze-
dried cylindrical scaffolds composed of COL, CS and/or HA, cross-linked with either 
EDC/NHS or genipin. If some other material component than the three is added to the 
scaffold matrix, such composites are presented at the bottom of each table. Some of the 
essential results of the studies are further presented and discussed in the following three 
chapters. 
3.4.1 Collagen and hyaluronic acid composite scaffolds 
A vast number of studies have demonstrated that COL+HA scaffolds have a positive im-
pact on cellular response [140, 22, 142, 107, 61, 83, 31, 18]. HA is known to accelerate 
tissue repair by promoting mesenchymal and epithelial cell migration and differentiation, 
thereby enhancing COL deposition and production in tissues [97]. These observations 
support the idea of combining COL and HA as a functional tissue engineering scaffold. 
In porous COL+HA scaffolds HA is known to play a part in the survival and proliferation 
of cells as well as the maintenance and regeneration of tissue by cell receptor (CD44), 
whereas COL is known to constitute the ECM in most tissues of the human body and to 
be advantageous for cell adhesion [59]. Moreover, Park et al. [26] have stated that the 
biological benefits of HA become present without mechanical limitations with the addi-
tion of HA in COL-based scaffolds, making the two even more beneficial as a pair. 
A study by Matsiko et al. [89] has revealed the ability of COL+HA scaffolds to facil-
itate MSC differentiation down to a chondrogenic lineage and to promote cartilage-spe-
cific matrix production in vitro. Furthermore, a study by Kim et al. [59] support the ben-
efits of HA and COL in cartilage regeneration. Fabricated COL+HA scaffolds underwent 
in vitro and in vivo tests, both showing positive results towards cartilage formation. In 
vitro cell culture test with human chondrocytes demonstrated increase in cell proliferation 
with greater COL concentration, even cell distribution and good adhesion. Following in 
vivo cell culture test with rabbits showed increased GAG concentration in COL+HA scaf-
folds compared to plain HA scaffold, indicating cartilage formation. [59] 
While HA and COL serve for cell adhesion and growth within the native cartilage 
ECM, they also provide the tissue with necessary tensile strength [96]. This statement is 
supported by a study conducted by Kim et al. [61]. Their results in tensile characterization 
of COL+HA scaffolds reported an increase in tensile strength with greater COL content, 
while simultaneously the nanofibrous structure of HA was thought to contribute to the 
enhanced mechanical strength. [61] Another study by Kim et al. [59] also confirmed that 
adding more COL in COL+HA scaffolds result in increased tensile strength. Furthermore, 
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another research group had evidence that with a higher HA content, the tensile strength 
of COL-based scaffolds could be increased [83].  
However, without any further processing of the mechanical properties of in vitro fab-
ricated scaffolds, they still quite often remain too weak to support heavy loads associated 
with cartilage tissue. Therefore it is often required to enhance the mechanical properties 
of fabricated scaffolds e.g. by cross-linking. [19] Two examples of such successful en-
hancement on mechanical properties are studies by Boss et al. [7] and Wang et al. [142], 
where they fabricated HA+COL-based scaffolds by freeze-drying and cross-linked them 
using EDC for better mechanical stability. In a study by Davidenko et al. [22] HA has 
even reportedly enhanced the EDC/NHS cross-linking efficiency.  
3.4.2 Collagen and chondroitin sulfate composite scaffolds 
For the past decade researchers have investigated the efficacy of using composite scaf-
folds composed of CS and other biopolymers such as COL or synthetic biodegradable 
polymers for cartilage tissue engineering [97]. Many studies have been reported on type 
I and II COL+CS scaffolds, in which they are produced either by co-precipitation of COL 
and CS, or by a covalent attachment of CS to collagenous matrix (ratios of COL:CS usu-
ally being 1.5-44:1) [128].  
Several investigations have revealed a strong correlation between the use of CS and 
the bioactivity of the seeded chondrocytes [97]. For example, in vitro cell culture test with 
bovine chondrocytes demonstrated a positive influence of CS on bioactivity of chondro-
cytes [138]. Chondrocytes are crucial for the adequate cartilage matrix balance and func-
tion because they are the only cells in articular cartilage [66]. van Susante et al. [138] 
demonstrated, how the proliferation of chondrocytes and the total amount of PGs and 
cells was significantly higher in COL matrix with CS present compared to plain COL 
scaffolds.  
In a number of other studies (in the Appendix 10) concerning the combination of COL 
and CS, CS has been shown to stimulate chondrogenesis in vitro [89, 147] and to maintain 
chondrocytic phenotype [36, 61]. Moreover CS has been shown to promote cellular in-
growth as well as cartilaginous tissue formation in vivo [89, 59], while COL have report-
edly increased tensile strength of the composite construct [21, 61]. In a study by Kim et 
al. [61] the seeded chondrocytes maintained round morphology throughout the experi-
ment (2 weeks) and only sparse elongated cells with fibroblastic appearance were de-
tected. In addition to promoting cartilage-specific cell viability and attachment, COL+CS 
scaffolds have been reported to support the viability, metabolic activity and proliferation 
of tendon cells [11]. 
Adding CS to a COL-based composite has been reported to bring many beneficial 
properties to freeze-dried composite scaffolds; including increased mechanical strength 
and water uptake abilities. Kangjian et al. [56] fabricated membrane shape, freeze-dried 
COL+Chi+CS scaffolds for skin tissue engineering purposes. From their tensile test re-
sults became clear that the addition of CS to COL+Chi-based scaffolds increased the me-
chanical durability of the matrix when compared to COL+Chi scaffolds without CS. [56] 
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Daamen et al. [21], in turn, fabricated freeze-dried COL+CS+ELN scaffolds, whose water 
binding abilities were shown to increase up to 65% with the attachment of CS. 
Douglas et al. [23] conducted an interesting interaction study between types I and II 
COL and different types of CS (CS-A, CS-B, CS-C). These composite scaffolds were 
composed of COL I/II+CS as a surface coating on titanium disks. COL was prepared as 
fibrils and cross-linked with EDC/NHS. The scaffold fabrication method of Douglas et 
al. [23] differed from the present study by not being freeze-drying but being fibrillogen-
esis instead. Nevertheless their findings are worth of mentioning in the present context. 
Their study demonstrated that COL II bound more CS (more precisely CS-C) than COL 
I. However, all CS types caused COL I/II fibrils to become thinner, and the fibrils of both 
COL types bound a higher mass of CS-C than CS-B and a greater mass of CS-B than CS-
A. [23] Evidently CS binding favors COL II, which is the dominant COL type in native 
cartilage [8]. These results could be important, when choosing COL or CS type for the 
construction of scaffolds for cartilage tissue engineering purposes. 
3.4.3 Collagen, hyaluronic acid and/or chondroitin sulfate composite 
scaffolds 
Matsiko et al. [89] expected a significant enhancement of the biofunctionality of COL-
based scaffolds for chondrogenesis with the addition of either HA or CS. Both variations 
(i.e. COL+HA and COL+CS) actually demonstrated ability to facilitate MSC differenti-
ation down to a chondrogenic lineage and to promote cartilage-specific matrix production 
in vitro. The results indicated also that the quality of the cartilage matrix, produced within 
COL+HA scaffolds was superior compared to COL+CS or GAG-free COL scaffolds (as 
early as 14 days). The COL+HA scaffolds showed greater levels of MSC infiltration as 
well as significant acceleration of early stage gene expression of type II COL and cartilage 
production compared to the COL+CS scaffolds. In the case of HA, the researchers spec-
ulated that HA might stimulate migration of MSCs into scaffolds conceivably through 
chemotaxis or through the high anionic charge of HA that may have altered the interaction 
of cells and matrices. [89]  
The results reported by Matsiko et al. [89] suggest that COL+HA scaffolds may have 
superior biochemical properties in terms of cartilage regeneration as opposed to COL+CS 
scaffolds. On the other hand the inclusion of both HA and CS to COL have also shown 
promising results. An interesting remark related to freeze-dried COL+CS+HA composite 
scaffolds is that so far there are only few studies in the literature associated with the com-
position of all three components [147, 63, 64, 36], indicating that the idea is relatively 
new. Since all the above mentioned investigations resulted in positive impacts on me-
chanical properties, swelling abilities, degradation, pore architecture and in vitro cell cul-
tures (see the Appendix 12 for details), it is evident that the combination of COL, HA and 
CS has been successful. Furthermore, the biochemical fact that speaks on behalf of com-
bining HA and CS to COL-based scaffolds is that CS and HA together with N-acetylglu-
cosamine (GlcNAc; found naturally in the body) are known to repair cartilage after sur-
gery. CS increases the synthesis of HA, glucosamine and COL type II in cartilage, while 
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it inhibits cartilage ECM degrading enzymes and therefore promotes cartilage repair in 
situ. [96] Moreover, HA have been reported to induce a variety of stimulatory signals to 
regulate chondrocyte proliferation as well as matrix synthesis in cartilage microenviron-
ment [51], thus facilitating the integration of engineered scaffold [147]. Consequently, 
the combination of COL+CS+HA may partly mimic the cartilage ECM and yield out 
biomimetic environment for chondrocytes when the cells are incorporated into the con-
struct [147]. Composite scaffolds with the composition of these three polymers have all 
been fabricated by freeze-drying (at some point of processing) and cross-linked with ei-
ther GP (mostly) [147, 63, 64], EDC/NHS [147], ADH [147] or by polymerization [36]. 
Biological criterion is not the only important aspect to be considered when designing 
a suitable scaffold for the cartilage regeneration. Mechanical properties of the scaffold, 
such as stiffness play a critical role in supporting proliferation, migration and differenti-
ation into a specific tissue. Collins et al. [19] and Murphy et al.  [94] elucidated the influ-
ence of CS and HA incorporated within COL-based scaffolds as well as the mechanical 
properties of finished constructs on MSCs. Their in vitro tests with MSCs suggested that 
the fate of the cells is dependent on the mechanical properties of COL+GAG scaffolds. 
Murphy et al. [94] demonstrated that by varying the stiffness of COL+CS and COL+HA 
scaffolds, the MSCs could be directed towards either chondrogenic (lowest stiffness) or 
osteogenic (highest stiffness) lineage. Their in vitro cell differentiation test results re-
vealed that scaffolds with the lowest stiffness (0.5 kPa) directed MSCs towards a chon-
drogenic lineage, whereas in the stiffest scaffolds (1.5 kPa) MSCs were differentiating 
towards an osteogenic lineage. Furthermore, it turned out that within the COL+HA scaf-
folds (compared to the COL+CS scaffolds) it was HA that further influenced MSCs to-
wards chondrogenic differentiation, whereas in the COL+CS scaffolds (compared to the 
COL+HA scaffolds) CS on MSC differentiation suggested an osteogenic influence. [94] 
Matsiko et al. [89] had similar kinds of results with their COL+HA/CS scaffolds. In their 
in vitro cell culture and gene expression tests the COL+HA scaffolds showed greater lev-
els of MSC infiltration compared to the COL+CS scaffolds. Also, the COL+HA scaffolds 
showed significant acceleration of early stage gene expression of type II COL and carti-
lage matrix production compared to the COL+CS  scaffolds. [89]  
3.5 Processing of porous scaffolds  
Highly porous structure is a necessity for a tissue engineering scaffold in order it to be 
fully replaced by living tissue after implantation in vivo. Interconnected pores enable cells 
to infiltrate within the scaffold matrix in vivo [72] as well as the diffusion of nutrients and 
waste products. [22] Moreover, it must provide sufficient temporary mechanical support 
and match the mechanical properties of the host tissue as closely as possible in order to 
bear in vivo stresses and loading. Therefore, the selection of materials together with suit-
able processing methods, is the key factor for producing applicable scaffolds. [111] Nu-
merous processing techniques have been developed for the manufacture of porous tissue 
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engineering scaffolds. Most commonly employed processing techniques are gathered in 
Table 3.1 and presented in short in the following paragraph.  
Electrospinning is a broadly used technique, which utilizes electrical forces to fabri-
cate electrostatic nanofibers and fabrics from polymer solutions or melts. In electrospin-
ning polymer solution is placed in a capillary tube, where it becomes subjected to an 
electric field. The repulsive electrical forces overcome the liquid surface tension forces 
and a charged solution is ejected from the capillary tip in form of thin fibers. The process 
can be set up vertically or horizontally; both presented in Figure 3.1. [4]  
 
        
(a)                    (b) 
 
Figure 3.1. Typical vertical (a) and horizontal (b) set-ups of electrospinning process. 
Modified from [4]. 
 
Rapid prototyping is a group of techniques (examples presented in Table 3.1) that are 
used to fabricate a scale model of a physical part or assembly utilizing 3D computer aided 
design (CAD) data. It has been referred to as layered manufacturing, solid free-form man-
ufacturing and computer automated manufacturing. [24] Porogen leaching and super crit-
ical fluid technology [19] both exploit porogens to create a porous structure. Porogen 
leaching involves mixing suitable porogen (usually inorganic salts) with a solution of 
polymer, after which the porogen is leached out during a casting procedure in order to 
form porous sponges. [129] Super critical fluid technology, in turn, uses gas that is dis-
solved in a polymer at high pressures. Porous structure is formed, when gas molecules 
are homogenously nucleated and thermodynamic driving force produce gas bubbles 
throughout the polymer. Polymer solution can be induced in several different ways with 
phase separation: non solvent induced phase separation, chemically induced phase sepa-
ration and thermally induced phase separation (TIPS). The basic principle is, however, 
similar in all of them: solvent is removed by extraction, evaporation or sublimation, while 
the polymer in the polymer-rich phase solidifies and the space occupied by the solvent 
becomes porous. There are several micro pattering techniques (examples shown in Table 
3.1), which are capable of producing 3D scaffolds with tailored microstructural proper-
ties. As an example of such tailoring is a femtosecond laser two photon polymerization 
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(TPP) technique that can produce 3D submicron patterns on hydrogel scaffolds with pre-
cise control of geometry. [19] Freeze-drying, which was the method of choice in the pre-
sent study, is presented in more detail in the next chapter. 
 
Table 3.1. Various fabrication and processing techniques that produce porous 3D scaf-
folds. UNS = unspecified. Modified from [19]. 
Processing 
technology  
Processing 
method 
Obtained 
porosity 
(%) 
Pore architecture Advantages Disadvantages Refe-
rence 
Electro-
spinning 
Needling < 95 Nanofibers 3D scaffolds 
and fabrics 
Limited control 
of pore size an 
shape, poor  
mechanical 
properties 
[19, 4] 
Rapid  
prototyping 
 
Solid free form  
fabrication 
 
Layer by layer  
deposition 
 
Bioprinting 
UNS Interconnected 
macro (various 
shapes), incorpora-
tion of biological 
molecules 
Controllable 
pore geometry 
and size scaf-
folds 
Difficult  
processing 
[19, 
24] 
Porogen 
leaching 
Casting and par-
ticulate leaching 
20-60 Spherical  3D scaffolds Limited control 
of pore size an 
shape 
[19, 
129] 
Phase  
separation 
Casting < 97 Interconnected 
micropore structure 
3D scaffolds Limited control 
of pore size and 
shape 
[19] 
Super  
critical 
fluid 
technology 
Casting < 95 Non-interconnected 
micro structure with 
interconnected 
macrostructure 
UNS UNS [19] 
Micro  
pattering 
 
Casting and 
femtosecond  
laser induced 
TPP 
 
Lithography 
 
Nanoimprinting 
> 90 Spherical Geometry 
control chemi-
cal cues in na-
noscale topog-
raphy, con-
trolled degra-
dation 
Slow processing [19] 
Freeze- 
drying 
Casting < 97 Interconnected  
micropore structure 
Easy pro-
cessing, 3D 
scaffolds 
Expensiveness, 
limited control 
of porosity 
[19, 7, 
143] 
 
Scaffold should possess over 90% porosity with a highly porous surface and microstruc-
ture in order to allow in vitro cell adhesion, ingrowth and reorganization. Different pore 
architectures (i.e. microenvironments) are required for different tissues and their regen-
eration. [111] All of the above-mentioned processes generate scaffolds with intercon-
nected pore structure [20] with varying degrees of porosity, pore size and architecture. 
With phase separation, salt leaching, freeze-drying and electrospinning it is possible to 
fabricate 3D models. Freeze-drying is often used because of the easy processing it in-
volves [7]. 
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3.5.1 Freeze-drying 
Freeze-drying, or lyophilisation [143] is a form of casting, which produces interconnected 
macro structure with pores size less than 200 µm and porosity less than 97% [19]. The 
general process in short is following: a solvent is removed from a frozen material or so-
lution by sublimation and by desorption, usually under reduced pressure (a vacuum). 
Freeze-drying can be divided into three stages: freezing, primary and secondary drying 
(Figure 3.2). [7] 
 
 
 
 
 
Figure 3.2. The steps of freeze-drying process. Modified from [7]. 
 
During the first step (freezing) the material in hydrogel form is cooled down to a temper-
ature below the solidification. During freezing the water in the solution forms dense pock-
ets (ice crystals) throughout the structure [19], which are then removed by sublimation 
and heat addition during the second stage (primary drying period). [7, 143] Heating of the 
product removes the unfrozen bound water and leaves behind a porous sponge network 
[19]. The last stage (secondary drying) clears the solvent from the sample chamber, while 
a small amount of sorbed water is removed by desorption. The performance of the overall 
process depends significantly on the stage and rate of the freezing as well as the processed 
material. Pore size, shape, distribution and connectivity depend on the ice crystals formed 
during the freezing stage [7], which can be controlled by exposing the material to different 
freezing conditions (e.g. -20°C and -80°C) [19]. [7] 
There are many advantages in freeze-drying. First, it involves easy processing and 
porous 3D scaffold formation. Secondly, the process preserves the original polymer struc-
ture of the material, while a fast transition of the moisture product minimizes several 
degradation reactions. Thirdly, a reduced pressure enables processing at low tempera-
tures, which is beneficial especially for the processing of thermosensitive polymers. The 
downsides of freeze-drying are limited control of porosity [19] and expensiveness [7]. 
The process also generates several freezing and drying stresses to the material such as 
formation of dendritic ice crystals, phase separation and pH changes [143]. 
The described process correspond a conventional freeze-drying method, where varia-
ble cooling rates (utilized throughout the scaffold during freezing) produce a heterogene-
ous matrix pore structure with a large variation in average pore diameter at different lo-
cations throughout the scaffold. This has been shown to lead to variable cell adhesion and 
to affect the ability of the cell to produce a uniform distribution of ECM proteins. [99] 
O’Brien et al. [99] have created a modified version of the process. In their study the scaf-
fold synthesis was modified to produce more homogeneous freezing by controlling of the 
rate of freezing during fabrication. The COL+CS scaffolds fabricated on constant cooling 
Primary 
drying 
Secondary 
drying 
Freezing  
of the product 
Porous  
end product 
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rate technique produced more homogenous solid scaffolds and did not show notable spe-
cial variation in pore size. In addition, the pores appeared to be more equiaxed than with 
scaffolds fabricated by the conventional quenching technique. The significant variations 
on the end results between both techniques can be observed in Figure 3.3.  
 
 
Figure 3.3. A series of longitudinal images taken via the fixed selection protocol from a 
single sheet of scaffold produced using the conventional, quenching freeze-drying tech-
nique (a) and the modified, constant cooling rate technique. Scale bar = 300 µm. Modi-
fied from [99]. 
 
Freeze-drying has been the traditional fabrication method for numerous COL, HA and/or 
CS composite scaffolds. With this technique it is possible to produce 3D scaffolds in 
various shapes and sizes, and the freezing rate and final freezing temperature can be ma-
nipulated to affect scaffold pore size and uniformity. [11] Numerous COL+CS-based 3D 
scaffolds of varying designs have been reported such as membrane shaped scaffolds for 
skin scaffolds and wound dressings [56] and cylindrical shaped scaffolds for tendon tissue 
engineering [10, 11]. In addition, fiber-reinforced scaffolds have been designed for tissue 
engineering in general [21] and for soft tissue and cartilage regeneration [117]. Further-
more, COL+CS chambers have been fabricated for peripheral nerve regeneration [41]. 
The majority of reported freeze-dried COL+HA 3D scaffolds have been disk shaped; in 
general for tissue engineering purposes [126], for cartilage and bone tissue engineering 
[59, 140] and for dermal restoration [106]. Other freeze-dried COL+HA scaffolds re-
ported include membrane shaped for tissue regeneration in general [107], sponge-like for 
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brain tissue engineering [142], antibiotic bi-layered matrices as skin substitutes [105] and 
microspheres developed for drug delivery as cell/tissue carriers and bone grafting [13]. 
COL+CS+HA 3D scaffolds have been fabricated by freeze-drying into cylindrical shaped 
[36, 147] as well as sponge-like [63]; all designed for cartilage tissue engineering. 
Overall, especially for cartilage tissue engineering purposes following freeze-dried 
COL+CS/HA/CS+HA scaffolds have been fabricated: disk [59, 140, 106, 128, 31], cy-
lindrical [36, 147, 10, 11, 47] and membrane [94, 107, 23] shaped, fiber reinforced [117] 
and sponge-like scaffolds [63, 142]. Details concerning all of the above mentioned re-
searches can be found in the Appendices 9-12. In the present study Telfon® molds, espe-
cially designed for fabricating 3D disk shaped scaffolds were used. This shape was con-
sidered beneficial for the purposes of the present study; i.e. easily achievable and suitable 
for testing of compression, swelling and water uptake. Furthermore, changes in the orig-
inal shape could be easily seen just by visual observation. 
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4 CROSS-LINKING METHODS FOR NATURAL 
POLYMERS 
Due to their polymeric nature most natural polymers have weak mechanical properties 
and poor durability against enzymatic degradation [104] that limit their usefulness for 
orthopedic applications. These issues can be solved e.g. by adding a second stiffer phase 
to the scaffold matrix or through various cross-linking mechanisms, which produce me-
chanically and chemically robust materials. [20, 19] Cross-linking methods differ in the 
extent of cross-linking and in use of different cross-linking agents [130]. Various cross-
linking methods include for example physical, chemical, auto- and photo-cross-linking 
[19]. Examples of chemical methods include the use of glutaraldehyde, carbodiimides 
and genipin, whereas common biophysical methods include the use of ultraviolet light 
and dehydrothermal cross-linking (DHT) [20]. With all crosslinkers, the degree of cross-
linking can be varied by controlling the duration, concentration and pH of the incubation 
[141]. 
In most cases, a chemical cross-link refers to a covalent structure between molecules. 
However, in some cases the term has also been used in a context of weaker chemical 
interactions. [53] An attachment between two functional groups on a single protein cre-
ates intramolecular cross-links (Figure 4.1 (a)), whereas the attachment between groups 
on two different proteins creates intermolecular cross-links (Figure 4.1 (b)) that stabilize 
a protein-protein interaction [130]. 
 
(a)  (b)  
 
Figure 4.1. A schematic presentation of intermolecular (a) and intramolecular (b) cross-
links. CL stands for cross-link, and CLer stands for crosslinker. Modified from [14]. 
 
Cross-linking reagents or crosslinkers are molecules that contain two or more reactive 
ends capable of chemically attaching to specific functional groups (e.g. primary amines, 
sulfhydryls, carboxyls) on proteins or other molecules [130]. Generating reactive sites for 
the chemical modification (i.e. covalent bonds) of the original molecule involves cleaving 
or attaching functional groups by for example hydrolysis, esterification, oxidation [131]. 
This process may alter significantly physicochemical properties of the native molecule, 
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but most derivatives retain their biocompatibility and biodegradability [19]. In principle, 
different crosslinkers can be divided into two groups. First are agents (e.g. glutaraldehyde, 
epoxy compounds and genipin) that can be used to bridge amino groups of lysine or hy-
droxylysine residues of different polypeptide chains by monomeric or oligomeric cross-
links. Second group (carbodiimides) forms direct cross-linking of the polypeptide chains. 
After a nucleophilic attack by free amino groups of lysine or hydroxyline residues, they 
result as amide-type cross-links. [123] 
Numerous cross-linking techniques, methods and cross-linking degrees have been 
shown to cause differing impacts on cellular response. The matter has been investigated 
for example by Vickers et al. [140] with porous 3D DHT and EDC/NHS cross-linked 
COL+HA scaffolds and MSCs. In their research they demonstrated the effects of various 
levels of the aforementioned cross-linking treatments on cellular condensation and chon-
drogenesis. The results indicated an increase in cell number densities and enhanced chon-
drogenesis with lower cross-linking densities compared to more highly cross-linked den-
sities. [140] 
In the present study the two chemical cross-linking methods applied to the scaffolds 
were EDC/NHS and genipin cross-linking. Compared to the well-established EDC cross-
linking agent, genipin is a novel addition to the more natural and less toxic crosslinkers. 
In the results part the EDC/NHS and genipin cross-linked scaffolds are compared and 
their possible differences assessed according to the mechanical, visual and microstruc-
tural properties of the scaffolds. The next two chapters provide theoretical information on 
these two crosslinkers.  
4.1 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hy-
drochloride / N-hydroxysuccinimide cross-linking 
1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDC, EDAC or EDCI 
[119]) is a representative of a chemical cross-linking agent [33]. It belongs to the class of 
zero-length crosslinkers (carbodiimides) that modify specific side-groups to permit cross-
link formation but do not become part of that linkage [75]. In contrast to conventional 
chemical agents such as bifunctional [75] glutaraldehyde or polyfunctional [75] poly-
epoxides, carbomiidies are simply converted to water-soluble 1-ethyl-3-(3-dimethyl-ami-
nopropyl)-urea that have very low cytotoxicity [107, 146].  
In proteins like COL, EDC cross-linking process modifies the primary amine (-NH2) 
and carboxyl (-COOH) side-groups of amino acids making them reactive with other side 
groups [75]. EDC has reportedly coupled groups that are located within 1.0 nm from each 
other, and thus has potential to form both intra- and intermolecular cross-links within or 
between tropocollagen molecules. However, carboxylic acid and amino groups located 
on two adjacent COL microfibrils are supposedly too far in order to be bridged. [123] 
Figure 4.2 shows the two reactive sites in the basic amino acid structure of proteins.  
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Figure 4.2. The two reactive sites in the amino acid structure of proteins. Modified from 
[1]. 
 
EDC reacts with a carboxyl group to form an amine-reactive O-acylisourea intermediate 
that facilitates bonding with an amine near-by. If O-acylisourea intermediate does not 
encounter an amine, it will hydrolyze and regenerate the carboxyl group. The conjugation 
reaction between O-acylisourea and an amine causes two protein molecules to become 
cross-linked with each other via an amide bond, while releasing EDC reagent as an 
isourea by-product. [131] Figure 4.3 illustrates the conjugation reaction of carboxylic acid 
to primary amines that EDC establishes in protein molecules. 
 
 
 
Figure 4.3. The EDC facilitated conjugation reaction of carboxyl-to-amine cross-link 
between protein molecules. Molecules (1) and (2) stand for peptides, proteins or any 
chemicals that have respective carboxylate and primary amine groups. Modified from 
[131]. 
 
Polysaccharides, such as HA and CS can be chemically cross-linked to form hydrogels 
because of their abundant functional groups. In GAGs like HA and in CS EDC targets the 
hydroxyl and carboxyl groups. [70, 97] EDC converts carboxyl groups into amides and 
mediates acid anhydride formation between two carboxyl groups belonging to the same 
or different HA/CS molecules. The resultant acid anhydride may readily react with hy-
droxyl groups of HA/CS to yield an ester bond, which functions as a covalent cross-link 
between molecules. [107] Figure 4.4 shows the two reactive sites on HA.  
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Figure 4.4. Principal reactive sites for chemical modification in HA. Similar sites are 
found in the structure of CS. Modified from [19]. 
 
EDC is commonly used in combination with N-hydroxysuccinimide (NHS).  It acts as a 
catalyst that intensifies the mechanism of EDC cross-linking. By suppressing side reac-
tions like hydrolysis, NHS induces more effective and stabilized reaction. [146] In the 
presence of NHS, EDC converts carboxylic groups to form activated NHS-esters that are 
considerably more stable than O-acylisourea intermediates (in Figure 4.3) [131]. Olde 
Damink et al. [101] have claimed that the addition of NHS to the EDC containing solution 
is a very effective way to increase the number of cross-links. This was determined by 
monitoring the free amino group content, which was significantly decreased with 
EDC/NHS present and thereby considered as a proof of higher degree of cross-linking. 
[101] 
The cross-linking with EDC/NHS has been reported to increase the mechanical 
strength [13, 108, 11, 117] and to decrease the swelling and water uptake [13, 142, 140, 
22, 127] of freeze-dried COL+HA or COL+CS scaffolds. In the studies by Wang et al. 
[142] and Chang et al. [13] the water uptake capacity has been reported to decrease in 
connection with increased cross-linking degree. Furthermore, with the increase of 
EDC/NHS cross-linking level the degradation ratio of similar scaffolds have shown to 
decrease [11, 61, 108, 117]. The effect of EDC/NHS cross-linking on the mechanical 
durability has also been widely studied. In most cases, the cross-linking has enhanced the 
mechanical durability of composite scaffolds.  Caliari et al. [11] and Shepherd et al. [117] 
have reported increase in tensile strength with greater cross-linking degree, while Pek et 
al. [108] have had similar results on compression strength. The degradation ratio has ev-
idently been shown to slow down after cross-linking according to investigations by Want 
et al. [142], Kim et al. [61], Pek et al. [108], and Kangjian et al. [56]. Moreover, Vickers 
et al. [140] studied the effects of EDC/NHS cross-linking treatment with COL+HA scaf-
folds on cell number densities. They discovered that scaffolds with low-crosslink densi-
ties resulted in an increase of cell number densities and in a greater degree of chondro-
genesis compared to more highly cross-linked that seemed to resists cellular contraction. 
[140] 
Determining the effects of EDC/NHS cross-linking on porosity, pore size and struc-
ture of freeze-dried COL+HA/CS scaffolds, following observations and results have been 
made. Numerous studies reported on freeze-dried COL+HA scaffolds [140, 22, 142, 106, 
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107, 105] and COL+CS scaffolds [138, 117] that maintained an open, interconnected pore 
structure after EDC/NHS cross-linking. A histologic examination by Vickers et al. [140] 
on COL+HA scaffolds revealed that the scaffolds of highest cross-link densities had the 
best looking porous structure (open and interconnected). Another study on similar scaf-
folds reported interconnected pore structure with total porosity of ~85% and no signs of 
COL denaturation during cross-linking treatment [22].  
Carbodiimides utilizing chemical cross-linking of proteins, polysaccharides and other 
biomolecules is a well-established procedure. However, this reaction is known to be non-
selective and to produce insignificant or very low chemical modification of the polysac-
charide, which is why researches are currently investigating alternative crosslinkers as 
well. [48] 
4.2 Genipin cross-linking 
Genipin is a natural cross-linking agent extracted as a hydrolytic product from geniposide 
(Figure 4.5 (a)), found in the fruits of Gardenia jasminoides ELLIS. Genipin itself is 
colorless but forms blue particles by spontaneous reaction with amino acid residues and 
proteins. [145] The structure of genipin, shown in Figure 4.5 (b), was discovered in the 
1960s. But since there were other more commonly used and inexpensive cross-linking 
agents available, such as synthetic glutaraldehyde (GTA) [123] it was not until the recent 
decade that genipin became a subject of extensive investigations. It was mainly the tox-
icity concerns associated with GTA [123] that led to the search for other less toxic and 
more natural crosslinkers [137] like genipin. Recent investigations include genipin cross-
linked gelatin for the use as a bioadhesive, wound dressing, bone substitutes [137] and 
cartilage tissue engineering scaffolds [80].  
 
 (a)     (b)      
 
Figure 4.5. The structure of geniposide (a) and its hydrolytic product, genipin (b). [145] 
 
Genipin has been used to cross-link for example COL gels [141], chitosan, proteins [145] 
and biological tissues [82]. It has been shown to affect the mechanical properties of COL 
II, bovine pericardium [124] and porcine tendon by increasing their tensile strength. In 
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addition, genipin has been studied for anti-inflammatory effects in vitro (directly to dif-
ferent cell lines) and in vivo (oral administration to animals). [82] 
As a crosslinker genipin can bridge amino groups of lysine or hydroxylysine residues 
of different polypeptide chains by monomeric or oligomeric cross-links but only via an-
other genipin molecule [123]. The cross-linking mechanism between a primary amine 
group and genipin still remains unclear in detail but Chang et al. [14] suggested following 
reaction shown in Figure 4.6 (a). Furthermore, the presumable reaction between genipin 
and the primary amine groups of COL is illustrated in Figure 4.6 (b). 
 
 
(a) 
 
(b) 
 
Figure 4.6. The presumable mechanism of amino group with genipin (a), and genipin 
cross-linking with COL molecules (b). Modified from [14]. 
 
With COL genipin forms intra- and intermolecular cross-links of the amino residues on 
tropocollagen or proteoglycan molecules [82]. As opposed to EDC, genipin can form ad-
ditional intermicrofibrillar cross-links [123], which result in better biostability of COL 
[144]. Genipin can reside stably as a modified cyclic form within the ECM by adding 
bridges across adjacent COL fibers [82]. When free amino groups of different COL mol-
ecules become cross-linked with each other, they form an interpenetrating polymeric net-
work (IPN) that lead to better biostability of COL [144]. Figure 4.7 shows a schematic 
presentation that illustrates the presumable genipin cross-links formed with tropocollagen 
molecules. 
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(a)     (b)   
 
(c)       
 
Figure 4.7. Genipin can form both intramolecular (a), intermolecular (b) and intermi-
crofibrillar (c) cross-links between tropocollagen molecules. Modified from [14]. 
 
In the field of tissue engineering only a few studies (since 2009) have been reported on 
genipin (GP) cross-linked composite scaffolds composed of COL, HA and/or CS [147, 
63, 64, 36]; details found in the Appendix 12. In fact, the GP cross-linked composite 
scaffolds have invariably been COL+CS+HA composites. From their results following 
findings can be concluded: a greater degree of GP cross-linking has resulted in a slight 
increase of compression strength [147], lower water uptake and swelling tendency [147, 
64] and decreased degradation rate [147, 63]. In these studies, the purpose of GP cross-
linking was specifically to improve the physical and chemical performance of the scaf-
folds such as compressive strength, water uptake, degradability, pore size and pore archi-
tecture. Zhang et al. [147] reported that with increased GP concentration following im-
provements could be achieved: a significant decrease in pore size (𝑐𝐺𝑃: 0  0.75 mM), a 
slight increase in compressive strength, lower water uptake (𝑐𝐺𝑃: up to 1 mM) and slower 
degradation. Ko et al. [63] had similar degradation results as Zhang et al. [147].  
Many research groups have revealed positive results concerning the effects of GP 
cross-linking on pore architecture. For instance, Zhang et al. [147] fabricated 
COL+CS+HA scaffolds that maintained interconnected and homogenously distributed 
pore structure after freeze-drying and GP cross-linking. Ko et al. [63] reported an inter-
connected pore structure and porosities of 92-95% after GP cross-linking in similar kinds 
of composite scaffolds. Ko et al. [64] provided varying porosity results on cross-linked 
COL+CS+HA scaffolds, cross-linked COL scaffolds and non-cross-linked scaffolds. The 
pore structure stayed intact in all of the variations; with the exception of surface pores 
collapsing slightly.  
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The effect of GP cross-linking on the degree of porosity has also been investigated. Ko et 
al. [64] reported that the porosity in GP cross-linked plain COL scaffolds was 95%, in GP 
cross-linked COL+CS+HA scaffolds 90% and in non-cross-linked COL scaffolds 96%. 
Scaffolds for tissue regeneration purposes should possess over 90% porosity in order to 
allow in vitro cell adhesion, ingrowth and reorganization. However, increased porosity 
(well over 90%) causes the scaffold to lose significantly its mechanical strength. In addi-
tion to the necessity of a certain porosity degree, the size and microstructure of the pores 
is equally important. Increased pore size causes decrease in the internal surface area. On 
the other hand, when pore diameter is too small, cells may provoke pore occlusion and 
prevent cellular penetration within the scaffold, which leads to an ingrowth of smaller 
pores and eventually fibrous tissue. Scaffold microstructure allow in vitro cell adhesion, 
ingrowth and reorganization, and ultimately result in the success or failure of the scaffold 
construct. [111]  
Currently there is no standard GP cross-linking procedure established. Many research-
ers have reported several more or less different practices; in terms of the concentration 
and the amount of GP cross-linking solution per scaffold, solvent in which the solid GP 
powder is dissolved, cross-linking time and temperature, washing procedures etc. The GP 
cross-linking procedure in the present study was carried out based on results collected 
from various sources (shown in the Appendix 8) and is explained in more detail in the 
Materials and Methods.  
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5 AIMS OF THE PRESENT STUDY 
 To study how to fabricate freeze-dried composite scaffolds from collagen, hyalu-
ronic acid and/or chondroitin sulfate that mimic natural cartilage composition. 
 To study the suitability of the fabricated scaffolds for cartilage engineering with 
compressive and microstructural testing. 
 To characterize water uptake, swelling and dimensional changes of the fabricated 
scaffolds. 
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6 MATERIALS AND METHODS 
6.1 Materials   
6.1.1 Collagen, hyaluronic acid, chondroitin sulfate 
COL solution (Type I, purified bovine dermal COL, PureCol®) with the COL concentra-
tion of 3.0 mg/ml used in the present study was purchased from Nutacon B.V. (Lei-
muiden, the Netherlands). Table 6.1 provides the product information of the used COL, 
HA and CS. HA sodium salt from Streptococcus equi and CS sodium salt from shark 
cartilage were purchased from Sigma-Aldrich Finland Oy (Helsinki, Finland). 
 
Table 6.1. Materials used to fabricate composite scaffolds.      
Material Product information  
Collagen Trade mark Advanced  
Biomatrix PureCol® 
Purified bovine, Type I 
Sterile solution in 0.01 N HCl, 
ccol = 3.0 mg/ml 
Hyaluronic acid Product number 53747  
CAS no 9067-32-7 
Sodium salt from Streptococcus 
equi, powder 
Chondroitin sulfate Product number C4384 
CAS no 9007-28-7 
Sodium salt from shark carti-
lage, powder 
6.1.2 Cross-linking agents 
Two different cross-linking agents were used in the present study: EDC/NHS and genipin. 
Detailed information concerning the crosslinkers is shown in Table 6.2. All crosslinkers 
were purchased from Sigma-Aldrich Finland Oy (Helsinki, Finland).  
 
Table 6.2. Crosslinkers used in the present study. 
Cross-linking agent CAS number MW  
[g/mol] 
Product number 
N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride 
25952-53-8 191.70  E1769 – 10g 
N-Hydroxysuccinimide 6066-82-6 115.09  130672 – 5g 
Genipin 6902-77-8  226.23  G4796 – 125mg 
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6.2 Methods   
6.2.1 Fabrication of scaffolds  
Prior to the actual scaffold fabrication preliminary composite scaffolds with varying 
COL, HA and CS compositions were fabricated to determine the most applicable compo-
site composition. Criteria for the selection of appropriate composition were: 1) scaffolds 
needed to hold their shape and size; 2) to endure cross-linking; and 3) testing. COL con-
centrations of 0.5 wt.% and 1.0 wt.% were blended separately in a ratio of 3:1 with either 
HA or CS of 0.05 wt.%, 0.5 wt.% and 1.0 wt.%. Detailed information about the prelimi-
nary composite scaffolds is shown in Table 6.3.  
 
Table 6.3. Preliminary composite scaffolds fabricated from COL, HA and/or CS. 
Scaffold composition and concentration 
0.5 wt.% COL + 0.05 wt.% HA 
0.5 wt.% COL + 0.05 wt.% CS 
1.0 wt.% COL + 0.5 wt.% HA 
1.0 wt.% COL + 0.5 wt.% CS 
 
To study the effects of the different components/compositions as well as the two different 
cross-linking treatments on the scaffolds, 11 different test groups with a specific COL, 
HA and/or CS compositions were fabricated. Four scaffold groups were cross-linked with 
GP and seven with EDC/NHS. Each test group composed of 6 parallel scaffolds. Names 
of the groups varied according to their composition and cross-linking treatment. Table 
6.4 shows detailed information of the scaffold groups, where C stands for “collagen”, H 
stands for “hyaluronic acid” and CS for “chondroitin sulfate”. E or G at the end stands 
for scaffolds cross-linked with “EDC/NHS” or “Genipin”, respectively. Numbers in the 
middle indicate the volume percentage of the blended components (0-100%, v/v). 
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Table 6.4. Actual test scaffold groups and their composition; more detailed information 
can be found in the Notations. 
Notations of the test 
scaffolds groups 
Interpretation of the abbreviations 
C100E 1.0 wt.% COL; EDC/NHS 
C100G 1.0 wt.% COL; GP  
C80HE 1.0 wt.% COL + 1.0 wt.% HA | 80:20 wt.%; EDC/NHS  
C80HG 1.0 wt.% COL + 1.0 wt.% HA | 80:20 wt.%; GP  
C60HE 1.0 wt.% COL + 1.0 wt.% HA | 60:40 wt.%; EDC/NHS  
C80CSE 1.0 wt.% COL + 1.0 wt.% CS | 80:20 wt.%; EDC/NHS  
C80CSG 1.0 wt.% COL + 1.0 wt.% CS | 80:20 wt.%; GP  
C60CSE 1.0 wt.% COL + 1.0 wt.% CS | 60:40 wt.%; EDC/NHS  
C80CS15HE 1.0 wt.% COL + 1.0 wt.% CS + 1.0 wt.% HA | 80:15:5 wt.%; 
EDC/NHS  
C80CS15HG 1.0 wt.% COL + 1.0 wt.% CS + 1.0 wt.% HA | 80:15:5 wt.%; 
GP  
C60CS30HE 1.0 wt.% COL + 1.0 wt.% CS + 1.0 wt.% HA | 60:30:10 wt.%; 
EDC/NHS  
 
The preliminary composite scaffolds were not cross-linked, and their suitability for test-
ing was assessed only visually. Concentrations of 1.0 wt.% COL, 1.0 wt.% HA and/or 
1.0 wt.% CS were chosen for the fabrication of the actual test scaffolds due to obvious 
reasons seen in Figure 7.3 (in the Results and Discussion).  
6.2.1.1 Preparation of blends and freeze-drying 
Fibrillogenesis buffer solution (pH 11.2) was used to process COL-HCl solution into a 
gel-like form. Sodium hydroxide (Product of EMD Millipore Corporation, USA) and 
85% phosphoric acid (Product of J.T. Baker®, Netherlands) were used to prepare fresh 
fibrillogenesis buffer monthly. Specific information concerning these reagents can be 
found in Table 6.5. Both reagents were purchased from VWR International Oy (Helsinki, 
Finland). 
 
Table 6.5. Reagents used for fibrillogenesis buffer preparation. 
Reagent CAS number MW  
[g/mol] 
Molecular 
formula 
Sodium hydroxide 12179-02-1 40.0  NaOH 
Phosphoric acid, 85% 7664-38-2 98.0 H3PO4 
 
For the gelation of COL, COL-HCl solution and fibrillogenesis buffer (0.2 M NaH2 PO4) 
were mixed in a ratio 10:1 and stirred gently with magnetic stirrer for 10-15 minutes. The 
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result was 0.3 wt.% COL gel from which the 1.0 wt.% Col-gel was prepared by centrifu-
gation (CF-510-A device, Labsystems Oy, Helsinki, Finland). Centrifugation was per-
formed at a rate of 5000 rpm at 20°C for 30 minutes, after which the correct amount of 
the clear solvent was removed with a pipette. The remaining COL pellet and remaining 
solvent was finally mixed with a spatula into a uniform COL gel. The pH of the Col-gel 
was adjusted to 7.2 with 1 M HCl or 1-10 M NaOH.  
Prior to the blending of COL, HA and CS, COL was processed into a gel-like form 
and HA and CS were dissolved in deionized water. The initial components of all prepared 
blends were 1.0 wt.% COL-gel, 1.0 wt.% HA-solution and 1.0 wt.% CS-solution. It was 
noticed that the 100 mg of HA did not dissolve easily (under 24 hours) in regular deion-
ized water (pH 7). Therefore, the dissolution to 1.0 wt.% HA-solution was performed 
according to Kim et al. [59]. CS seemed to dissolve easier in regular deionized water, but 
to ensure the same starting point, it was decided that both HA and CS was dissolved in 
deionized water (pH 3.2-3.5). The dissolution was performed in a magnetic stirrer (RT) 
at the maximum speed (1000-11000 rpm) for 1-1.5 hours.  
After preparation of individual components, they were blended together gently with 
a spatula in a volume per volume ratios (%) of 80:20, 60:40, 80:15:5 and 60:30:10 
(COL:HA/CS/CS:HA); COL being the most abundant component in all of the blends. 
The blends were then injected into polytetrafluoroethylene (Teflon®) molds (d = 8 mm, h 
= 2 mm, Figure 6.1) through an injection needle, placed into a freezer for 24 hours (-
30°C) and finally freeze-dried for 24 hours. The freeze-dryer (Figure 6.2) used in the 
present study was Heto RYWINNER with Heto CT 110 Cooling Trap (Jouan Nordic A/S, 
AllerØd, Denmark), attached to ILMVAC Rotary Vane Pump, Type PK 4 Dp (ILMVAC, 
Ilmenau, Germany).  
 
   
(a)                   (b) 
 
Figure 6.1. Polytetrafluoroethylene molds used in the present study; as disassembled (a) 
and as assembled (b).  
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Figure 6.2. The freeze-dryer used in the present study.  
6.2.1.2 Cross-linking 
Freeze-dried scaffolds were cross-linked with either EDC/NHS or GP. The washing pro-
cedures after cross-linking, in both cases, were following: 5 minutes with 50% ethanol, 2 
x 10 minutes with deionized water and 2 x 5 minutes in deionized water in an ultrasonic 
washer. The amount of ethanol or water was 10 ml (minimum) per scaffold at each stage 
of the washing. The EDC/NHS cross-linking solution was prepared by dissolving 14 mM 
EDC and 6 mM NHS in 95% ethanol. Each scaffold was immersed in 10 ml of EDC/NHS-
solution for 4 hours in room temperature (RT). Immediately after washing scaffolds were 
placed in Teflon® molds, kept in the freezer (-30°C) for 24 hours and finally freeze-dried 
for 24 hours.  
No standard GP cross-linking procedures is yet established in the literature, and there-
fore the GP cross-linking conditions were decided according to the amount of GP pur-
chased and based on information collected from numerous sources (shown in the Appen-
dix 8). In the present study 0.1 wt.% GP-solution was prepared by dissolving GP powder 
in 70% ethanol,  and each scaffold was immersed in GP-solution (1.5 ml/scaffold) for 48 
hours at 37°C.  
After the EDC/NHS or GP cross-linking treatments, 6 scaffolds with the best structure 
from each group were selected by visual observation for the compression, swelling, FTIR 
and micro-CT testing. Prior and between the testing, all fabricated scaffolds were stored 
in a vacuum cabinet. 
Vacuum pump 
A sample container is 
placed in one of the  
3-port manifolds 
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6.2.2 Characterization of scaffolds 
For the characterization of the scaffolds, following methods were chosen: compression 
testing for dry and wet scaffolds (including study on the recovery from compression), 
water uptake and dimensional changes upon water uptake (swelling), FTIR spectroscopy 
and micro-CT imaging. All tests were carried out using 6 parallel scaffolds from each of 
the 11 different scaffold groups, with the exception of FTIR and micro-CT tests that were 
carried out on only one scaffold per group. EDC/NHS and GP cross-linked scaffolds 
grouped separately. For the names of the test groups see Table 6.4. Exceptionally, FTIR 
imaging was performed also for non-cross-linked scaffolds (one per each test group). 
6.2.2.1 Water uptake and dimensional changes 
The weights of the scaffolds were measured both in dry and wet conditions with a digital 
scale with an accuracy of 0.01 mg. For water uptake and dimensional changes upon water 
uptake characterization 6 parallel scaffolds from each scaffold group were soaked in 5 ml 
phosphate buffered saline solution (PBS) for 24 hours (37ºC). Two different methods 
were performed while weighing of the wet scaffolds (detailed descriptions on the next 
page). Fresh PBS (pH 7.4) was prepared every 2 weeks from reagents specified in Table 
6.6 and according to the instructions seen in Table 6.7. All reagents in Table 6.6 are Prod-
ucts of J.T. Baker®, Netherlands and were purchased from VWR International Oy (Hel-
sinki, Finland). 
 
Table 6.6. Reagents used for phosphate buffered saline solution. 
Reagent CAS num-
ber 
MW 
[g/mol]  
Molecular  
formula 
Sodium hydrogen phosphate, 
anhydrous 
7558-79-4 141.96  Na2HPO4 
Sodium dihydrogenophosphate, 
monohydrous 
10049-21-5 137.99  Na2HPO4 * H2O 
Sodium chloride 7647-14-5 58.44  NaCl 
 
Table 6.7. The instructions for the preparation of phosphate buffered saline solution. 
Reagent 5 liters of PBS 
(pH 7.4) 
Na2HPO4 17.700 g 
Na2HPO4 * H2O 3.775 g 
NaCl 29.500 g 
 
The dimensions (diameter and height) of both dry and wet scaffolds were measured with 
a digital slide gauge with an accuracy of 0.01 mm. The comparable wet weight measure-
ment was done to soaking wet scaffolds because filter drying causes the scaffolds to 
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shrink. The diameter and height change percentages were calculated with Equations 1 and 
2. 
 
                            𝐷𝑖𝑎𝑚𝑒𝑡𝑒𝑟 𝑐ℎ𝑎𝑛𝑔𝑒 (%) =
𝑑𝑆𝑊−𝑑𝐷
𝑑𝐷
 ,     (1) 
 
where 𝑑𝑆𝑊 stands for the diameter measured from the scaffold in soaking wet condition 
and 𝑑𝐷 for the diameter measured from the scaffold in dry condition. 
 
                            𝐻𝑒𝑖𝑔ℎ𝑡 𝑐ℎ𝑎𝑛𝑔𝑒 (%) =
ℎ𝑆𝑊−ℎ𝐷
ℎ𝐷
 ,     (2) 
 
where ℎ𝑆𝑊 stands for the height measured from the scaffold in soaking wet condition and 
ℎ𝐷 for the height measured from the scaffold in dry condition. 
 
Two different water uptake characterizations were performed on the wet scaffolds to as-
sess their ability to absorb water. In the first water uptake characterization the scaffolds 
were lifted from PBS with tweezers, shaken gently to eliminate excess liquid drops and 
weighed soaking wet without drying (SW). With this method the ability of the scaffold 
structure to absorb water was determined as a whole (the material and the pores). After 
the first weighing, scaffolds were placed back in PBS (37ºC) for 1 hour. After 1 hour of 
recovery, the second water uptake characterization of the scaffolds was performed to 
determine the water absorption of the scaffold material itself (no excess water inside the 
pores). In this second method the same wet scaffolds were dried 15 seconds per side with 
filter paper and weighted again as filter dried (FD). The water uptake measurements were 
determined by calculating the change in weight between dry and wet condition of the 
scaffolds. The water uptake percentages were calculated by using Equations 3 and 4.  
 
            𝑊𝑎𝑡𝑒𝑟 𝑢𝑝𝑡𝑎𝑘𝑒 𝑜𝑓 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 𝑎𝑛𝑑 𝑝𝑜𝑟𝑒 𝑠𝑦𝑠𝑡𝑒𝑚 (%) =
𝑤𝑆𝑊−𝑤𝐷
𝑤𝐷
 ,  (3) 
 
where 𝑤𝑆𝑊 stands for the soaking wet weight and 𝑤𝐷  for the dry weight of the scaffold.  
 
 
                               𝑊𝑎𝑡𝑒𝑟 𝑢𝑝𝑡𝑎𝑘𝑒 𝑜𝑓 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 𝑜𝑛𝑙𝑦 (%) =
𝑤𝐹𝐷−𝑤𝐷
𝑤𝐷
 ,  (4) 
 
where 𝑤𝐹𝐷 stands for the filter dried weight and 𝑤𝐷 for the dry weight of the scaffold.  
6.2.2.2 Compression strength 
To determine compression properties, scaffolds were tested both dry and wet with Bose 
BioDynamic ElectroForce 5100 instrument (Figure 6.3). The manufacturer of the device 
is Bose (Minnesota, the United States) and the model is 5160 with a Bose 50 lbf load 
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transducer. Six parallel scaffolds from each scaffold group were tested to gain statistical 
value to the results. Scaffolds were placed between two compression platens shown in 
Figure 6.3. Tests parameters were: distance between compression platens (mm), com-
pression speed (mm/min), preset value (N), scan time (s), and scan points (pcs). Com-
pression was set to proceed up to 70% from the initial height, at the speed of 5 mm/min. 
Due to the small size of the scaffolds, preset value was used to enable similar initial 
setting prior to compression. The machine lowered the upper compression platen by com-
ing in contact with each scaffold to the point, where pre-determined preset value was 
reached. Preset value for dry scaffolds was set to 1.5 N and for wet scaffolds 0.7 N. The 
preset value for the wet scaffolds had to be adjusted into lower value because they were 
much softer compared to the dry scaffolds. After scaffold loading between the compres-
sion platens and presetting, distance of the platens was measured and used to calculate all 
the other parameter values. The scaffold became compressed by the lower platen moving 
up towards the stationary upper platen.  
 
 
Figure 6.3. Bose BioDynamic ElectroForce 5100 instrument for compression testing. 
 
Compression data (load and displacement values) was obtained from the software, and 
translated into stress-strain figures. The compressive modulus and compressive stiffness 
values were determined as mean ± standard deviation (SD) from 6 parallel scaffolds of 
each test group.  
Compressive modulus, or elastic modulus equals the slope of the linear region of 
stress-strain diagram. The elastic region ranges up to the elastic limit, beyond which the 
Upper compression platen 
(stationary) 
Sample 
Lower compression platen  
(upwardly mobile) 
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material breaks or no longer goes back to its original shape, when load is removed. It is 
also the maximum stress that can be applied to the material without permanent defor-
mation. Equation 5 presents the relationship and direct proportionality of stress (σ), strain 
(ε) and compressive modulus (E). [112] 
 
                                             𝜎 = 𝐸𝜀         (5) 
 
The compressive modulus was defined as the slope of the linear region of each stress-
strain curve. The linear region was defined as 7-11 % strain with dry scaffolds and 9 %-
21 % strain with the wet scaffolds. The stress-strain curves of the wet scaffolds had a lot 
of interference (explained in more detail in the Results and Discussion). Therefore, the 
linear region of the wet scaffolds (from which the compressive modulus was obtained) 
was defined from a longer region to compensate the extensive interference. The compres-
sive stiffness for each scaffold group was also determined from the compression data. 
Equation 6 shows that stiffness (k) is defined as load (or force, F) divided by displacement 
(x) caused by the load [3]. 
 
                                             𝑘 =
𝐹
𝑥
        (6) 
 
In connection with determining compression properties, scaffolds were tested for their 
ability to recover after the compression. Scaffold dimensions (d and h) were measured 
before and after the compression; recovery time being 10 minutes (RT) with the dry scaf-
folds and 1 hour in PBS (37ºC) with the wet scaffolds. Equations 6 and 7 were used to 
determine the ability of the scaffolds to return to their original size after the load had been 
removed.  
 
                  𝐷𝑖𝑎𝑚𝑒𝑡𝑒𝑟 𝑐ℎ𝑎𝑛𝑔𝑒 𝑎𝑓𝑡𝑒𝑟 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑦 (%) =
𝑑𝐴𝐶−𝑑𝐵𝐶
𝑑𝐵𝐶
    (7) 
 
where 𝑑𝐵𝐶 stands for the diameter measured from the dry/wet scaffold before compres-
sion, and 𝑑𝐴𝐶 for the diameter measured from the dry scaffold after 10 minutes recovery 
(RT) or from the wet scaffold after 1 hour recovery in PBS (37°C). 
 
                  𝐻𝑒𝑖𝑔ℎ𝑡 𝑐ℎ𝑎𝑛𝑔𝑒 𝑎𝑓𝑡𝑒𝑟 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑦 (%) =
ℎ𝐴𝐶−ℎ𝐵𝐶
ℎ𝐵𝐶
,    (8) 
 
where ℎ𝐵𝐶 stands for the height measured from the dry/wet scaffold before compression, 
and ℎ𝐴𝐶  for the height measured from the dry scaffold after 10 minutes recovery (RT) or 
from the wet scaffold after 1 hour recovery in PBS (37°C). 
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6.2.2.3 Fourier transform infrared spectroscopy and micro-com-
puted tomography 
FTIR spectroscopy was used to investigate the differences in the biochemical composi-
tions of scaffolds before and after EDC/NHS and GP cross-linking. FTIR spectrum pro-
vides information on the molecular structure of materials. Assignment of the absorption 
peaks associated with major functional groups, such as amide, hydroxyl and carboxyl 
groups [132] help to identify specific chemical bonds, atoms and molecules as well as 
their movements relative to each other (e.g. bending, stretching [52]) [58].  
A basic IR spectrum is presented as a diagram of either absorbance or transmittance 
percent on the vertical axis and frequency or wavelength on the horizontal axis. Absorb-
ance is usually translated to transmittance, since the manual spectral libraries are provided 
in transmittance scale. Usually (and also in the present study) IR spectrum shows the 
intensity axis as transmittance per cents (0-100%). The analyzing of FTIR spectral data 
is further explained and discussed in the Results and Discussion. In the present study, the 
level of cross-linking was not analyzed from the FTIR diagrams, since it would have 
required additional methods (see the Results and Discussion). 
FTIR spectroscopy imaging took place in the Department of Chemistry and Bioengi-
neering at the Tampere University of Technology. Tests were performed with a potassium 
bromide (KBr) pellet method. The instrument used was Perkin Elmer Spectrum One FTIR 
Spectrometer (Waltham, MA, USA). 1-2 mg of each scaffold was milled, mixed with 200 
mg of KBr powder and compressed (8.6 t, 10 min.) into a thin pellet. Each pellet was 
placed one by one into the spectrometer to obtain scaffold-specific spectral data. Types 
of the chemical bonds within the scaffolds were identified mainly according to the corre-
lation tables by Tuure-Pekka Jauhiainen [52].  
Micro-CT uses X-ray to produce image files that can be compiled to generate 3D 
images, from which quantitative analysis of material properties can be obtained without 
physically interfering with the scaffolds [81]. Micro-CT has been extensively used to im-
age animal tissues (in vitro) [81], live animals (in vivo), metal etc. [45]. Micro-CT systems 
are typically optimized for spatial resolution to obtain an image that approaches histolog-
ical microscopy as closely as possible. It provides images that retain information about 
3D connectivity, density, topology and microarchitecture; with spatial resolution of 15–
50 µm over a field view of 15-50 mm. [45]  
The aim for micro-CT imaging in the present study was to obtain information on the 
inner pore structure and architecture and to see the possible differences that the different 
compositions and cross-linking treatments may have brought to the construct. Micro-CT 
scan and the reconstruction of the scaffolds were performed by M.Sc. Eng. Markus Han-
nula from Tampere University of Technology (Department of Electronics and Commu-
nications Engineering). Scanned area was 1 mm x 1 mm x 1 mm of each scaffold. Porosity 
and pore size data together with micro-CT images (available also in the Appendix 5) are 
presented in the Results and Discussion. 
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7 RESULTS AND DISCUSSION 
7.1 Preliminary scaffolds 
In cartilage tissue HA forms the backbone in complex proteoglycan structures immobi-
lized in a COL network and CS chains attached to it [6]. COL II contributes 50-60% of 
cartilage’s dry weight, proteoglycans 30-35% and non-collagenous proteins the rest 
[148]. In the adult cartilage GAGs form 15% of the cartilage’s dry weight, from which 
approximately 85% consists of CS and 6% of HA [25]. The compositions of 
COL+HA/CS/CS+HA scaffolds in the present study were designed based on the afore-
mentioned information on natural cartilage composition.  
In the beginning it was unclear, what would be the most beneficial compositions the 
three components (COL, HA, CS) should be blended in. It was also necessary to study 
the individual concentrations in which the components should be mixed in order to pro-
duce a successful scaffold. There were several requirements that needed to be taken into 
account. First, COL, HA and CS solutions needed to be stiff enough to produce a scaffold 
construct that would stay in its 3D shape and simultaneously liquid enough to be blended 
homogenously. In addition, HA and CS powders had to be totally dissolved into the sol-
vent (deionized water) within less than 24 hours.  
After fabrication and prior to further steps (cross-linking and testing) the scaffolds 
were evaluated visually. Criteria for the selection were that the scaffolds should not con-
tain separate phases, lumps, wrinkles etc., their shape and size should correspond to the 
molds they were fabricated in and the scaffolds should not collapse after removing them 
from the molds. Finally, they should be able to endure cross-linking and testing. All the 
different concentrations of the components of preliminary scaffolds, studied prior to ac-
tual scaffold fabrication are listed in Tables 7.1 and 7.2. 
 
Table 7.1. The concentrations of the components studied prior to blending. 
Component Concentrations 
(wt.%)  
COL 0.5, 1.0 (v/v) 
HA 0.05, 0.5, 1.0 (m/v) 
CS 0.05, 0.5, 1.0 (m/v) 
 
 
 
 
 
 
 
47 
 
Table 7.2. The preliminary composite scaffolds. 
Blends Concentrations 
(wt.%) 
Mixing  
ratios (v/v) 
COL + HA 
 
0.5 + 0.05 
1.0 + 0.5  
1.0 + 1.0 
3:1 
3:1 
3:1 
COL + CS 
 
0.5 + 0.05 
1.0 + 0.5 
1.0 + 1.0 
3:1 
3:1 
3:1 
 
HA solution was viscous with all the three different concentrations used. However, the 
1.0 wt.% solution was notably more viscous than the other two making it difficult to blend 
HA homogenously with more liquid CS solution. When preparing 1.0 wt.% HA solution, 
deionized water (pH 7) turned out to be ineffective as a solvent. After adjusting the water 
to pH 3.2-3.5, 100 mg of HA powder was successfully dissolved in it. Plain HA and CS 
solutions were fabricated into freeze-dried scaffolds (Figures 7.1-7.2) in order to select 
the best concentration for further scaffold fabrication with COL.  
 
0.05 wt.%       0.5 wt.%         1.0 wt.% 
     
                   
                   1 cm 
 
Figure 7.1. Preliminary plain HA scaffolds after freeze-drying.  
 
0.5 wt.%             1.0 wt.% 
 
 
                1 cm 
 
Figure 7.2. Preliminary plain CS scaffolds after freeze-drying.  
 
CS solution turned out to be highly nonviscous with all three concentrations. Thus it was 
speculated, whether CS could be fabricated into freeze-dried scaffold without other com-
ponents and whether it would withstand the cross-linking treatment. It turned out that 
with 0.05 wt.% CS there was no CS left in the Telfon® molds after freeze-drying, and 
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thus there are no 0.05 wt.% CS scaffolds to shown in Figure 7.2. However, with the con-
centrations of 0.5 wt.% and 1.0 wt.% the CS scaffolds could be fabricated (Figure 7.2). 
From the Figures 7.1 and 7.2 it can be seen that the plain 1.0 wt.% HA and CS scaf-
folds turned out the best. Also the shape of the 1.0 wt.% scaffolds corresponded most the 
intended 3D matrix; having no obvious wrinkles, holes or twists. The extra peak on top 
of the 1.0 wt.% scaffold is caused due to excess solution material coming over from the 
mold. Furthermore, since there were no obvious separate phases detected in the freeze-
dried scaffold, the 1.0 wt.% solution appeared to be distributed evenly, fulfilling the 
whole mold.  
Next step was to test the scaffold fabrication with different concentrations. After gen-
tle mixing to avoid air bubbles, blends were freeze-dried into 3D scaffolds to see the final 
outcome of different concentrations. The blending of 0.5 wt.% COL with 0.05 and 0.5 
wt.% HA, or 0.05 and 0.5 wt.% CS was tested, but the fabricated composite scaffolds 
were too thin and coarse. Also, the highly liquid nature of the CS solution raised concerns 
about the scaffolds holding its shape after freeze-drying and cross-linking. Therefore, it 
was decided that 1.0 wt.% COL was used in all of the following blends as well as in the 
final (actual) scaffold fabrication. The concentrations and mixing ratios of the preliminary 
composite scaffolds are listed in Table 7.2. and Figure 7.3 shows photographs taken from 
some of the manufactured preliminary composite scaffolds. 
 
(a)                 (b)                      (c) 
 
 
                           1 cm 
 
(d)                 (e)                      (f) 
 
 
                    1 cm 
Figure 7.3. Preliminary COL+HA/CS composite scaffolds. 
 
Based on visual characterization between freeze-dried scaffolds (Figures 7.1-7.3), the 
blend of 1.0 wt.% COL + 1.0 wt.% HA/CS appeared to produce the best scaffolds. The 
preliminary test scaffolds were cross-linked with EDC/NHS after freeze-drying in order 
(a) 0.5 wt.% COL + 0.05 wt.% HA  
(b) 1.0 wt.% COL + 0.5 wt.% HA 
(c) 1.0 wt.% COL + 1.0 wt.% HA 
(d) 0.5 wt.% COL + 0.05 wt.% CS  
(e) 1.0 wt.% COL + 0.5 wt.% CS 
(f) 1.0 wt.% COL + 1.0 wt.% CS 
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to evaluate their stability after processing. Their suitability for testing was assessed visu-
ally. All preliminary composite compositions appeared to endure the cross-linking treat-
ment without collapsing or shrinking significantly.  
Actual test scaffolds were composites of COL+HA, COL+CS and COL+CS+HA and 
the final compositions of the scaffolds were decided based on natural cartilage composi-
tion [137, 23]: COL as the predominant component (80 or 60 wt.%) and the rest of being 
either HA and/or CS. In COL+CS+HA composites COL was mixed together with more 
CS than HA, as they are in native cartilage tissue. The final compositions and concentra-
tions of the actual test scaffolds are presented in Table 7.3. 
 
Table 7.3. The final blends, concentrations and component compositions of the actual 
test scaffolds. 
Blends Concentrations 
(wt.%) 
Blend compositions 
(wt.%), i.e. (v/v) 
Notations 
COL + HA 
 
1.0 + 1.0 
(v/v) + (m/v) 
80:20  
60:40 
C80H 
C60H 
COL + CS 
 
1.0 + 1.0 
(v/v) + (m/v) 
80:20 
60:40 
C80CS 
C60CS 
COL + CS + HA 
 
1.0 + 1.0 + 1.0 
(v/v) + (m/v) + (m/v) 
80:15:5 
60:30:10 
C80CS15H 
C60CS30H 
 
Scaffolds in Table 7.3 were freeze-dried after blending and cross-linked with either 
EDC/NHS or GP. Additional test group (a control group), not seen in the Table 7.3 was 
1.0 wt.% COL (C100). Figure 7.4 shows some examples of the best and worst scaffolds 
after fabrication; additional photographs of the scaffolds are in the Appendix 1 (the pho-
tographs of the scaffolds before and after cross-linking). 
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C100 best        worst 
       
 
                    1 cm 
 
C80H best         worst   C60H best     worst 
 
  
 
C80CS best         worst  C60CS best     worst  
 
  
 
C80CS15H best      worst        C60CS30H best   worst 
 
   
      
Figure 7.4. The actual test scaffolds after fabrication by freeze-drying, including exam-
ples of the most (best) and the least (worst) successful scaffolds. 
 
Visual examination of the actual scaffolds after freeze-drying (Figure 7.4) revealed that 
all combinations and compositions produced rather similar looking scaffolds. When com-
paring the most successfully fabricated scaffolds (best in Figure 7.4), none of them 
seemed to be significantly better or worse than others. However, the differences became 
clearer when observing the least successful scaffolds. The compositions of C80H/CS, 
C80CS15H and C60CS produced the best overall looking scaffolds. These four groups 
maintained smooth surface as well as rounder and thicker shape even with the least suc-
cessful scaffolds, whereas the C60H, C60CS30H and C100 scaffolds appeared thinner, 
more lumpy or coarse. These observations ultimately led to the decision that all groups 
with only 60 wt.% COL would be omitted from GP cross-linking. However, all the scaf-
folds were cross-linked with EDC/NHS.  
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7.2 Cross-linking 
The actual test scaffolds were cross-linked after freeze-drying with either EDC/NHS or 
GP, after which they were freeze-dried for the second time. Since the visual characteriza-
tion of the 80 wt.% COL containing composite scaffolds generally showed better struc-
ture than the 60 wt.% COL containing scaffolds; the former were chosen for the GP treat-
ment. EDC/NHS cross-linking was carried out to all of the scaffold groups.  
Figure 7.5 presents some of the photographs taken before and after EDC/NHS or GP 
cross-linking. Photographs taken after GP treatment revealed that GP colored the scaf-
folds dark grey. This is a common effect reported in the literature caused by GP reacting 
with free amino acid residues [145, 147]. The best scaffolds from each scaffold group are 
shown in Figure 7.5 as an example of the effect that the cross-linking treatments had on 
the scaffolds. The Appendix 1 shows the photographs of all the different scaffolds, taken 
before and after the cross-linking treatment. 
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C100E                        C100G  
             
    
                      1 cm 
C80HE                 C80HG    
    
 
C80CSE                 C80CSG  
    
 
C80CS15HE                 C80CS15HG  
    
 
C60HE                 C60CSE       
    
 
C60CS10HE      
 
 
Figure 7.5. Photographs of the scaffolds taken before and after EDC/NHS or GP cross-
linking. Images show the most successful scaffold structure of each group. Note that the 
adjacent images are most likely taken from different scaffolds. 
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All GP cross-linked scaffolds experienced approximately 0.5-1 mm shrinkage in diameter 
(data not shown), whereas the EDC/NHS treated scaffolds shrunk even less in diameter. 
In fact, some of the C100E and C80HE scaffolds managed to maintain their diameter 
intact and only maximum of 0.2 mm shrinkage was seen in other EDC/NHS treated scaf-
folds. However, the biggest shrinkage in diameter was seen with the EDC/NHS cross-
linked CS containing scaffolds. Especially the C60CSE scaffolds shrunk noticeably; in 
some cases as much as 2 mm. The C60CSE as well as C80CS15HE and C60CS30HE 
scaffolds did not maintain their round and even shape but instead appeared as flatten and 
rough edged. The same phenomenon was seen with some of the C80CSG scaffolds and 
with the C100E and C80CS15HG scaffolds. It is noteworthy that even though the shape 
of the plain COL scaffolds suffered after EDC/NHS cross-linking treatment, their diam-
eter remained close to the one measured before cross-linking. Note that the differences in 
diameter of the scaffolds are better seen in the photographs presented in the Appendix 1 
as a contrast to the images shown in Figure 7.5.  
After EDC/NHS treatment a majority of the scaffolds also showed shrinkage in height 
(data not shown), whereas GP made most of the scaffolds slightly thicker; evident espe-
cially with the C100G and C80HG scaffolds (Figure 7.5). Besides intramolecular and 
short-range intermolecular cross-links formed with EDC/NHS and GP, additional long-
range intermolecular cross-links are formed in connection with GP cross-linking [77], 
resulting in scaffolds that hold their shape better. The C100G and C80HG scaffolds also 
seemed to have smoother surface after being treated with GP. However, the other two 
groups, i.e. C80CSG and C80CS15HG looked quite the opposite. In fact, the GP cross-
linked C80CS and C80CS15H scaffolds did not only shrunk more in height but they also 
appeared significantly more uneven and rough. All in all, these two groups were the least 
successful scaffolds after GP cross-linking. In addition, especially the C80CSG and 
C80CS15HG scaffolds did not for some reason withstand the second freeze-drying, 
and/or the multiple washing procedures involving gentle shaking. During these steps 
some inner pores may have collapsed and/or some small pieces become detached from 
the scaffolds resulting in such poor appearance. 
Scaffold groups that held their original shape and size the best after GP cross-linking 
were the C100 and C80H scaffolds. The most damaged groups after GP treatment were 
C80CS and C80CS15H. As a comparison, the groups that endured the EDC/NHS cross-
linking the least, both in diameter and in height were the C60CS, C80CS15H and 
C60CS30H scaffolds. It seems that both cross-linking treatments caused especially CS 
containing composites to lose their round and even shape, in addition to their original 
thicker size. The fact that plain CS scaffolds dissolved entirely into the 50% ethanol dur-
ing washing procedures, raised concerns that the washing steps might have dissolved 
some of the CS from the CS containing composites regardless of being cross-linked. This 
could be the reason, why the CS containing composites looked inferior after cross-linking 
treatments compared to the scaffolds without CS. Washing of plain CS scaffolds was 
furthermore tested with 95% ethanol, in which the scaffolds did not dissolve and with 
deionized water, in which the plain CS scaffolds dissolved totally. 
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When comparing the EDC/NHS and GP treated scaffolds, it is evident that both produced 
visually different looking scaffolds; in terms of size, shape and surface. Even though there 
has not been reported results between GP and EDC/NHS cross-linked freeze-dried scaf-
folds, Sung et al. [123] used GP comparatively with EDC for cross-linking of biological 
tissues. They found out that GP cross-linking was slower than carbodiimide cross-linking 
and that the tissue fixation with GP versus EDC may produce distinct cross-linking struc-
tures. [123] The different outcome of the GP treatment as opposed to EDC/NHS treatment 
is most likely due to the fact that GP forms additional intermicrofibrillar cross-links be-
tween COL molecules, whereas the EDC forms only intrahelical and interhelical cross-
links. The additional intermicrofibrillar cross-links between adjacent COL microfibrils 
affect significantly on the mechanical properties such as shrinkage and ruptured pattern 
of the GP treated material [123]. However, in the present study there were only four GP 
cross-linked groups to compare between the seven EDC/NHS cross-linked groups. There-
fore, in order to be certain which of the two crosslinkers could produce better looking or 
otherwise superior scaffolds it is recommendable to study this more widely in the future.  
Regardless of being treated with either EDC/NHS or GP, all the scaffolds in every 
group shrunk in diameter; the GP cross-linked more than the EDC/NHS cross-linked scaf-
folds. The reason for this could be the cross-linking treatment itself and/or the second 
freeze-drying. The second time freeze-drying could have broken both the inner pore struc-
ture as well as the outer surface of some of the less successfully fabricated scaffolds caus-
ing them to shrink noticeably. Visually the most damaged scaffolds after EDC/NHS 
cross-linking were the CS containing scaffolds and after GP treatment the plain COL and 
C80CS15H scaffolds. Park et al. [107] reported results that support the assumption that a 
cross-linking treatment could be the reason for the shrinkage of freeze-dried scaffolds. A 
slight decrease in the porosity and pore size of the COL+HA membranes that Park et al. 
[107] fabricated by freeze-drying (at -20°C) was noticed; indicating shrinkage of the con-
structs. Furthermore, Sung et al. [123] stated that the shrinkage of EDC/NHS or GP cross-
linked tissues are due to a contraction of the COL network, which may be associated with 
intrahelical, interhelical (EDC and GP) or intermicrofibrillar (GP) cross-links introduced 
into the COL fibers. These observations support the visual observations that the scaffolds 
can indeed shrink to some extent after either of the two cross-linking treatments.  
Individual differences seen between the scaffolds of a same group are most likely due 
to different microstructures formed in the scaffolds during fabrication. This was due to 
the processing method (freeze-drying), where many different characteristics, such as tem-
perature gradients during the procedure influenced to the final structure of the fabricated 
scaffolds. These could not have been avoided during selection of the scaffolds for cross-
linking treatments, since the microstructure is not visible to the naked eye. In addition, 
some of the scaffolds were significantly smaller than others, which may have caused them 
to suffer more during the cross-linking.  
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7.3 Microstructure of the scaffolds 
Scaffold microstructure effects the in vitro cell adhesion, ingrowth and reorganization 
and ultimately results in the success or failure of the scaffold construct [111]. TE scaffold 
should possess an interconnected pore structure with high porosity (usually exceeding 
90%) [111] and with large surface/volume ratios in order to provide sufficient space for 
cell growth and proliferation [22]. Moreover, the pore interconnectivity directly influ-
ences to the diffusion of physiological nutrients and gases to cells as well as to the re-
moval of metabolic waste and by-products from cells. [111] In the present study the po-
rosity, pore size and structure of the different scaffolds were studied with micro-CT im-
aging. Figure 7.6 shows series of micro-CT images of the scaffolds. In addition, the ma-
terial thickness, porosity and pore size data is presented in Table 7.4. Additional micro-
CT images are available in the Appendix 5.  
 
 
Figure 7.6. Micro-CT images of the scaffolds: C100E (A), C100G (B), C80HE (C), 
C80HG (D), C80CSE (E), C80CSG (F), C60HE (G), C60CSE (H), C80CS15HE (I), 
C80CS15HG (J) and C60CS30HE (K). Scale bars are 500 µm on the left frame and 300 
µm on the right frame. 
A B 
C D 
E F 
G H 
I J 
K 
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Table 7.4. The porosity, material thickness and pore size data of the scaffolds obtained 
from micro-CT imaging. 
 
Scaffold   
group 
Porosity 
[%] 
Material data Porosity data 
Material 
thickness  
[µm] 
(mean ± SD) 
Max.  
material 
thickness 
[µm] 
Pore size  
[µm] 
(mean ± SD) 
Max.  
pore size  
[µm] 
C100E 88 7 ± 2 17 26 ± 10 70 
C100G 92 7 ± 2 15 36 ± 10 78 
C80HE 94 7 ± 2 17 54 ± 16 112 
C80HG 91 7 ± 2 14 38 ± 12 83 
C60HE 92 6 ± 2 16 40 ± 13 92 
C80CSE 89 7 ± 2 19 57 ± 25 145 
C80CSG 91 7 ± 2 17 41 ± 14 99 
C60CSE 90 7 ± 2 17 54 ± 21 125 
C80CS15HE 91 7 ± 2 15 40 ± 13 101 
C80CS15HG 88 7 ± 2 23 37 ± 6 132 
C60CS30HE 91 7 ± 2 15 57 ± 22 118 
7.3.1 Porous structure of the scaffolds 
The A-K images (in Figure 7.6) show a 3D reconstruction of each scaffold (on the left 
taken from 1 mm x 1 mm x 1 mm area) and a 2D cross-sectional view (on the right). 
Images E, F, H-K in Figure 7.6 represent the CS containing scaffolds. The inclusion of 
CS to COL may be the reason for greater voids seen in most of their microstructure; 
particularly visible in images E, H and K. The effect of CS on the microstructure of the 
scaffolds is also seen, when comparing the COL+CS scaffolds to the corresponding 
COL+HA scaffolds. Both EDC/NHS and GP cross-linked CS containing scaffolds had 
bigger pores compared to the CS containing scaffolds; evident from the data shown in 
Table 7.4. The plain COL scaffolds had the smallest pores. In a study by Douglas et al. 
[23] CS was reported to be the reason for COL fibrils to become thinner. The data in 
Table 7.4 demonstrate that the maximum material thickness in the COL+CS scaffolds is 
slightly bigger than in the COL+HA scaffolds. Obviously the inclusion of CS to COL did 
not have similar effect on the material thickness of the scaffolds fabricated in the present 
study. 
In Figure 7.6 the images B, D, F and J represent the GP cross-linked scaffolds. When 
comparing the EDC/NHS cross-linked scaffolds to the GP cross-linked, the latter treat-
ment seems to have produced scaffolds with a denser pore structure as well as smaller 
pore sizes (more clearly visible from the additional micro-CT images in the Appendix 5). 
In fact, this can be observed in all the images of the scaffolds with the exception of plain 
COL scaffolds, where the C100E (image A in Figure 7.6) scaffold appear significantly 
more compact and denser than the C100G (image B in Figure 7.6) scaffold. The data 
shown in Table 7.4 support the aforementioned observation by demonstrating smaller 
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pore sizes (and denser microstructure) in GP cross-linked scaffolds compared to corre-
sponding EDC/NHS cross-linked scaffolds; only exception being, again the C100 scaf-
folds. The denser microstructure of the GP scaffolds could be explained by the intermi-
crofibrillar cross-links that GP creates between COL molecules pulling the adjacent COL 
microfibrils closer to each other. Similar cross-links are not known in connection with 
EDC treatment [123], therefore resulting in bigger voids seen in the EDC/NHS cross-
linked scaffolds. 
Even though the microstructure of all the scaffolds was demonstrated as highly porous 
and interconnected, some heterogeneity (i.e. presence of large pores, local regions of 
higher density etc.) is also visible in the micro-CT images. Some heterogeneity is seen in 
the microstructure of the C80CS15H/G scaffolds, whereas in the C80HE, C60HE and 
C80CSE/G scaffolds the heterogeneity is more dominant. In the case of COL+HA scaf-
folds this may be due to the relatively high concentration of COL or COL+HA suspension 
(1 wt.%) used in the scaffold fabrication. The viscous nature of the two solutions may 
have caused somewhat heterogeneous blending. Instead, with the groups containing CS 
the cause of heterogeneity may be due to the blending of the extremely liquid CS to much 
more viscous COL and/or HA solutions.  
7.3.2 Porosity 
The data in Table 7.4 shows that all the scaffolds had high porosity ranging from 88% to 
94%. The lowest porosity (88-89%) was detected with the C80CS15HG, C100E and 
C80CSE scaffolds. The three scaffold groups with the highest porosities (92-94%) were 
the C80HE and C60HE and C100G scaffolds. Tissue engineered scaffolds should possess 
over 90% porosity in order to allow the infiltration and growth of cells. However, an 
increased porosity of well over 90% can cause the scaffold to lose significantly its com-
pressive strength. [111] The compressive modulus result obtained from the C80HE scaf-
folds (Table 7.4) demonstrated that their well over 90% exceeding porosity (94%) did not 
affect their compressive properties negatively, when comparing their compressive mod-
ulus to the scaffolds with a lower porosity (Figures 7.9-7.10). 
GP cross-linked scaffolds have been reported to exhibit porosities as high as 90-95% 
[64, 63]. In the present study the porosity of GP cross-linked scaffolds ranged from 88% 
to 92%. The porosities obtained from EDC/NHS cross-linking were between 88% and 
94%. As a conclusion, both treatments showed optimal porosity values without being 
significantly better or worse over the other.  
Further comparison between the corresponding EDC/NHS and GP cross-linked scaf-
folds revealed that the C100G and C80CSG scaffolds had higher porosities than the 
C100E and C80CSE scaffolds, whereas the C80HG and C80CS15HG scaffolds had lower 
porosities than the C80HE and C80CS15HE scaffolds. In study by Ko et al. [64] the po-
rosity was reported lowest in cross-linked COL+CS+HA scaffolds (90%) compared to 
cross-linked plain COL scaffolds (95%) and to non-cross-linked COL scaffolds (96%). 
Based on the results of Ko et al. and on the results of the present study, the porosity of 
the scaffolds may rather be affected by the varying compositions of the raw materials than 
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the cross-linking treatment. By analyzing the COL+HA and COL+CS compositions, it 
appears that in the GP cross-linked scaffolds HA could rather be the reason for the slight 
decrease in the porosity of the composites than CS. However, despite of the different 
cross-linking methods and scaffold compositions the porosity values of all the scaffolds 
were rather similar. Thus, these minor differences can also be due to the fabrication pro-
cess. 
7.3.3 Pore size and material thickness 
In addition to a sufficient degree of porosity, generating a specific pore size and pore 
structure must be taken into account in order to produce a successful tissue engineered 
scaffold. Pores must be large enough to allow migration and ingrowth of the cells towards 
the center of the scaffolds. At the same time pores should be sufficiently small in order to 
provide adequate ligand density for cellular attachment. [22] When pores become too 
large, the internal surface area of the scaffold decreases. On the other hand, when the pore 
size is too small (pore diameter less than ~10 µm), it can prevent cellular penetration 
within the scaffold and eventually result in ingrowth of fibrous tissue. [111] The ideal 
pore size depends not only on the purpose of the scaffold but is also defined based on 
whether it should endure high mechanical strength or not. In addition, different cell and 
tissue types may need different amount of space when reorganizing the scaffold matrix.  
In the present study the pore sizes of the fabricated scaffold ranged from 26 µm to 57 
µm (Table 7.4). The biggest pores (over 50 µm) were detected in the C80HE, C80CSE, 
C60CS30HE and C60CSE scaffolds. Scaffolds with the smallest pores (under 40 µm) 
were C100E, C100G, C80CS15HG and C80HG. A study by Griffon et al. [35] support 
the idea that larger (70-120 µm) interconnective pores improve the cellularity and matrix 
content within the scaffold and potentially produce a larger construct in less time. On the 
other hand, pores smaller than 50 µm in diameter are recommended in order to improve 
mechanical strength of engineered constructs. Furthermore, small pores (supposedly 
ranging from 2.5 to 6.5 nm) are naturally present in the native cartilage matrix. [65] Based 
on these two arguments, scaffolds with small pores may nevertheless be the best choice 
towards successful chondrogenesis [35]. 
Matsiko et al. [89] have reported results, in which the addition of HA to COL caused 
a significant reduction in scaffold mean pore size compared to COL+CS and plain COL 
scaffolds. The results of the present study suggest otherwise. Plain COL (both EDC/NHS 
and GP treated) as well as the C80CS15HG scaffolds demonstrated smaller pore sizes 
compared to any of the COL+HA scaffolds. In fact, the pores in the C100E scaffolds were 
significantly smaller compared to all other scaffolds. The image A in Figure 7.6 as well 
as the data in Table 7.4 support this. Not much can be deduced based on the micro-CT 
images taken from one scaffold, but one explanation to this could also be that the selected 
plain COL scaffold could simply have had smaller pores than other fabricated COL scaf-
folds.  
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In the study by Ko et al. [64] the researchers cross-linked type II COL (COL2) and 
COL2+HA+CS scaffolds with GP and demonstrated that CS and HA decreased the po-
rosity of the scaffolds compared to plain COL (cross-linked and non-cross-linked) scaf-
folds. Similar results were obtained also in the present study, since the porosity of all 
COL+CS+HA scaffolds were smaller than the GP cross-linked plain COL scaffolds. 
However, it should be noted that the EDC/NHS cross-linked C100 scaffolds had lower 
porosity than the C60CS30HE and C80CS15HE (and C100G).  
In general, the pore sizes differed more than the material thickness between the scaf-
folds. In fact, the wall thickness of the scaffolds remained roughly the same regardless of 
the composition or the cross-linking treatment (Table 7.4). The data in Table 7.4 shows 
that the four scaffolds with the thickest pore walls all contained CS to some extent. This 
is an interesting remark, since the CS solution in the blending phase seemed almost too 
liquid to be fabricated into a solid construct. It may be that the inclusion of highly liquid 
CS to more viscous plain COL or COL+HA solution diluted the blend and caused bigger 
pores. Furthermore, when the total amount of polymer in the blend is the same in all of 
the scaffolds, the end result is seen as thicker pore walls.    
It should be noted that the micro-CT images were taken from one visually selected 
scaffold per each group. Therefore, the selected scaffolds could have contained inner de-
fects (collapsed pores, separate phases) that have affected the results. 
7.4 Compression testing 
A tissue engineered scaffold should have sufficient mechanical strength during the whole 
in vitro culturing in order to maintain the open pore structure required for cell ingrowth 
and matrix formation. With sufficient compressive strength and compressive stiffness, 
ability to recover etc. the structural integrity of the scaffold is possible to retain until the 
newly grown tissue is able to support loads and stresses and can assure its structural role. 
[111] In the present study the mechanical properties of the scaffolds were evaluated by 
performing compression tests separately on both dry and wet scaffolds. The small size of 
some of the scaffolds, especially from groups C60CS, C80CS15H and C60CS30H made 
it difficult to measure the compression properties of the scaffolds accurately. Compres-
sive modulus of the different scaffolds are shown in Figures 7.9-7.10. Compressive mod-
ulus results of relatively similar scaffolds of other studies are shown in the Appendix 7 
for comparison. However, varying fabrication and cross-linking methods, scaffold sizes 
and shapes as well as any additional processing steps should be taken into account when 
comparing the results.  
7.4.1 Compressive modulus 
The compressive stress-strain curves of the scaffolds are shown in Figure 7.7 (dry scaf-
folds) and in Figure 7.8 (wet scaffolds). The curves present one scaffold from each group, 
chosen as the best representative scaffold from each group. Additional stress-strain dia-
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grams are available in the Appendices 3 (dry) and 4 (wet).  Figures 7.9 show the com-
pressive modulus of the dry scaffolds and Figure 7.10 the compressive modulus of the 
wet scaffolds. 
 
 
Figure 7.7. The compressive stress-strain curves obtained from the dry scaffolds.  
 
 
Figure 7.8. The compressive stress-strain curves obtained from the wet scaffolds.  
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Figure 7.9. Compressive modulus results of the dry scaffolds. Results shown as mean ± 
SD. 
 
 
Figure 7.10. Compressive modulus results of the wet scaffolds. Results shown as mean ± 
SD. 
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As it can be seen from the compressive stress-strain curves in Figure 7.7, the stress values 
of the dry scaffolds rose steadily after the linear region (approximately up until 15% of 
strain). Instead, in the stress-strain curves of the wet scaffolds (Figure 7.8) the stress val-
ues stayed relative low until 40% of strain. In both cases the slope of the curves increased 
rapidly after 50-60% of strain, demonstrating the final densification regime [87]. Due to 
the lower stress values and the higher interference seen in the stress-strain curves of the 
wet scaffolds (Figure 7.8), the area of linear region (from which their compressive mod-
ulus values were determined) was longer than the linear region of the dry scaffolds.  
Comparison between Figures 7.9 and 7.10 show the difference in compressive mod-
ulus of the dry and wet scaffolds. As it was expected, the dry scaffolds had significantly 
higher compressive modulus than the corresponding wet scaffolds. The compressive 
modulus values of the dry EDC/NHS cross-linked scaffolds were approximately 6-13 
times higher compared to the corresponding wet scaffolds. The difference between the 
dry and wet scaffolds was even greater when comparing the groups of GP cross-linked 
scaffolds. The dry GP-scaffolds exhibited approximately 10-22-fold compressive modu-
lus values compared to the similar wet scaffolds.  
The three dry scaffold groups that had the highest compressive modulus (C80CSG, 
C80CS15HG and C60CSE) all contained CS. Similarly, the three groups that had the 
highest compressive modulus of the wet scaffolds (C60CSE, C60CS30HE and 
C80CS15HG) also contained CS. From these results it can be deduced that that the inclu-
sion of CS to plain COL and COL+HA could have a positive effect on compression prop-
erties. Kangjian et al. [56] have reported somewhat similar results. According to them CS 
was the reason for the increase in the tensile strength of COL+Chi+CS scaffolds (com-
pared to COL+Chi scaffolds). However, from the results of the present study it should be 
noted that one of the CS containing scaffolds (wet C80CS15HE) showed the lowest com-
pressive modulus. Other two scaffold groups with the lowest compressive modulus were 
wet C80HG and C60HE scaffolds.  
From the results presented in Figure 7.10 it should be noted that the compressive 
modulus obtained from wet C80CS15HE scaffolds is partially controversial. Due to this 
is the fact that half of the scaffolds (3/6) gave values that needed to be excluded from the 
mean calculations. Moreover, the three abandoned values differed from each other to the 
extent that it is recommended to perform similar measurements with similar scaffolds in 
the future to get more reliable results for this combination. There was no obvious reason 
that could explain why half of the measurements of the C80CS15HE scaffolds failed. 
However, one explanation could be the small size of the scaffolds that caused too much 
interference to the measurements.  
In summary, the biggest compressive modulus values measured from the dry scaffolds 
were C80CSG, C80CS15HG and C60CSE, and from the wet scaffolds C60CSE, 
C60CS30HE and C80CS15HG. Lowest compressive modulus values were obtained in 
terms of both dry and wet scaffolds from the C60HE and C80HG scaffolds. From these 
results it can be deduced that the compositions of either COL+CS or COL+HA effected 
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more on the compressive properties of the scaffolds than the different cross-linking treat-
ments. In general, both dry and wet CS containing composites exhibited higher compres-
sive modulus than the HA containing composites. 
It should be noted that the compression machinery used in the present study is very 
sensitive. Thus some unintentional shaking of the table (where the equipment was on) 
could have caused some high individual peaks in the stress-strain curves. Especially the 
wet compression testing was extremely challenging due to the small size and softness of 
the scaffolds. This caused extensive interference; seen as clusters of high peaks through-
out the stress-strain curves of the wet scaffolds (in the Appendix 4). Moreover, couple of 
the smallest wet scaffolds did not reach the 70% compression because the two compres-
sion platens came too close to each other, causing the machine to abort prematurely. How-
ever, this did not affect the overall compressive modulus and compressive stiffness re-
sults, since any exceptional values were excluded from the mean calculations.  
7.4.2 Compressive stiffness 
The compressive stiffness values were determined form the compression data. Figures 
7.11 and 7.12 show the compressive stiffness of the dry and wet scaffolds. The particu-
larly high SDs seen with some of the wet scaffold results (Figure 7.12) are caused by the 
small size of the scaffolds that complicated the measurements. 
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Figure 7.11. Compressive stiffness results of the dry scaffolds. Results shown as mean ± 
SD. 
 
 
Figure 7.12. Compressive stiffness results of the wet scaffolds. Results shown as mean ± 
SD. 
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In most cases the difference between the compressive stiffness of the dry and wet scaf-
folds was not as significant as expected. All the 60 wt.% COL containing composites 
demonstrated roughly the same compressive stiffness in both dry and wet states. The rest 
of the dry scaffolds were approximately 3-4 times stiffer than the corresponding wet scaf-
folds. The two most notable differences in the compressive stiffness results were seen 
with the C80CSG and C80CS15HE scaffolds; the C80CSG scaffolds demonstrated over 
12-fold greater compressive stiffness and the C80CS15HE scaffolds 8.5-fold greater 
compressive stiffness in dry versus wet state. 
From the Figures 7.11 and 7.12 it can be stated that in general all three 60 wt.% COL 
containing scaffolds demonstrated higher stiffness than the C100E and C80HE/G scaf-
folds. However, in this context the notably high SDs related to the C60-scaffolds should 
be noted, and therefore these results are not to be considered as 100% accurate. The high 
SDs are most definitely caused by the exceptionally small size of the C60-scaffolds that 
caused severe interference to the stress-strain curves. 
From the results of the wet scaffolds, the stiffest were the C60HE, C60CS30HE and 
C100E scaffolds, whereas the C80CS15HE, C80HE and C80CSG scaffolds were the least 
stiff. However, the extremely high SD values has to be considered when observing the 
results of the wet scaffolds, and therefore these results are somewhat open to interpreta-
tions. As a comparison, the three stiffest dry scaffolds were C80CSG, C80CS15HG and 
C80CS15HE, and the three dry scaffold groups with the lowest compressive stiffness 
were C80HG, C80HE and C100E. In the case of the C80CSG and C80CS15HE scaffolds 
interesting remarks can be made from these results: in wet state the two groups exhibited 
the lowest compressive stiffness values, whereas in dry state these groups were the stiff-
est. Similarly, but with opposite results can be noticed from the C80HE scaffolds: in dry 
state they were among the stiffest, whereas in wet state they were among the least stiff. It 
should be noted that all the compressive stiffness results of the wet C60-scaffolds as well 
as the dry results of the C80CSG scaffolds had significantly high SDs. 
When a porous scaffold is highly hydrophilic and absorbs lots of water, it becomes 
softer and thus the compressive stiffness of the scaffold usually decreases. In fact, this 
assumption is supported by the water uptake results (Figure 7.16 and 7.17) versus the 
compressive stiffness results (Figure 7.11) of the corresponding scaffolds. The most clear 
correlation of compressive stiffness with water uptake is seen with the results of the 60 
wt.% COL containing scaffolds.  
7.4.3 Recovery from compression 
Compression testing involved additional investigation on the ability of the scaffolds to 
recover after the compression. The dimensions of all the scaffolds were measured prior 
to the compression and re-measured after a defined recovery time. The recovery time for 
the dry scaffolds was 10 minutes in RT and 1 hour in PBS (37°C) for the wet scaffolds. 
Figure 7.13 shows the diameter change and Figure 7.14 the height change of both dry and 
wet scaffolds after the recovery from compression.  
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Figure 7.13. The diameter change of the scaffolds after compression. The recovery 
times after compression were 10 minutes (RT) for the dry scaffolds and 1 hour for the 
wet scaffolds (PBS, 37°C). Results shown as mean ± SD. 
 
 
Figure 7.14. The height change of the scaffolds after compression. The recovery times 
after compression were 10 minutes (RT) for the dry scaffolds and 1 hour for the wet 
scaffolds (PBS, 37°C). Results shown as mean ± SD. 
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First, it should be noted that the results shown in Figures 7.13 and 7.14 have exceptionally 
high SDs. Therefore, even though the values presented in Figures 7.13 and 7.14 vary 
widely between the individual scaffolds, the relative high variation in SDs indicates some-
what similar values between the scaffolds. And thus, especially the axial recovery of the 
dry scaffolds as well as the radial recovery of both dry and wet scaffolds, respectively are 
not significantly different between the different scaffold types. The smallest SDs are seen 
with the axial recovery results of the wet scaffolds (Figure 7.14). Therefore, from Figure 
7.14 it can be stated more certainly that the scaffolds that demonstrate the least recovery 
in height are the C60HE scaffolds. Moreover, it can be stated that most of the COL+HA 
scaffolds recovered overall better than the COL+CS scaffolds, when the exceptionally 
high SDs of the latter scaffold groups are taken into account. 
Overall, the wet scaffolds managed to recover as well as 85-99% of the initial height 
and 85-100% from their initial diameter. The dry scaffolds recovered up to 46-70% from 
their initial height and 97-100% from their initial diameter. These results show that the 
recovery between the dry and wet scaffolds was relatively similar. The biggest difference 
was that the axial recovery of the dry scaffolds was somewhat poorer compared to the 
other results.  
Interestingly some of the wet scaffolds demonstrated an increase in height after the 
recovery from compression, whereas all the dry scaffolds showed only decrease in height. 
In terms of height recovery (and when taking the result-specific SDs into account) the 
C80CSE, C60CSE and C60CS30HE scaffolds seemingly recovered the best from the dry 
scaffolds. As to diameter, some groups of both dry and wet scaffolds showed also increase 
in dimension. However, since most of the radial results of the wet scaffolds have notably 
high SDs, these results are somewhat controversial.  
Exceptionally high SDs were noticed in most of the diameter change results of both 
dry and wet scaffolds and with some of the height change results of the wet scaffolds. 
This is explained by the fact that some of the parallel scaffolds experienced shrinkage 
while some of them experienced expansion upon recovery. Furthermore, it is highly pos-
sible that the measuring of the small and soft scaffolds with a slide gauge could have 
created some error to the results. The biggest challenge was to maintaining the measuring 
procedure identical for every scaffold. The height and diameter were measured from the 
highest and widest part of each scaffold, but the re-measuring of the dimensions after the 
recovery may have been performed on a slightly different place than initially. In addition, 
the soft and sponge-like nature of the scaffolds made it difficult to avoid any squishing of 
the scaffolds during the measurements. Finally, it should be noted that the recovery results 
obtained from only one measuring place in the scaffold may not represent the overall 
recovery of the scaffold. Since not all of the scaffolds were perfectly even, round and 
homogenous, their recovery to the original shape might not have happened similarly in 
all directions causing some regions of the scaffold recover more while others remained 
more unchanged.  
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7.5 Water uptake  
The water uptake ability is an important property of a tissue engineering scaffold, since 
it relates to the diffusion of signaling molecules, nutrients and waste products [111]. In 
the present study the water uptake characterization was performed by two weighting 
methods. The first wet weighting method (first water uptake characterization) was to de-
termine the ability of the scaffold structure as a whole, i.e. the pores and the material 
itself. The second wet weighting method (second water uptake characterization) evalu-
ated the water uptake of the scaffold alone without the water being inside the pores.   
As an example, Figure 7.15 shows one scaffold from the C100E group and one from 
the C100G group in dry, soaking wet (SW) after immersion in PBS for 24 hours and filter 
dried (FD) states. The rest of the photographs taken from other groups in similar states 
are shown in the Appendix 3. The first water uptake characterization results are presented 
in Figure 7.16 and the second characterization results in Figure 7.17.  
 
(a) 
 
 
 
(b) 
 
 
 
Figure 7.15. EDC/NHS (a) and GP (b) cross-linked plain COL scaffolds in dry, soaking 
wet (SW) and filter dried (FD) states. SW shows the scaffold after immersion in PBS 
(pH 7.4) for 24 hours and FD after being dried between filter papers. 
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Figure 7.16. The water uptake of the scaffold and the pore systems. Values obtained from 
the first wet weighting. Results shown as mean ± SD. 
 
 
Figure 7.17. The water uptake of the scaffolds only. Values obtained from the second wet 
weighting. Results shown as mean ± SD. 
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Figures 7.16 and 7.17 show the difference between the different wet states (first and sec-
ond weighting) of the scaffolds. In both Figures the four scaffold groups with the highest 
water uptake abilities were C100G, C80HG, C80HE and C80CSG; demonstrating a dif-
ference only in the order of these groups between the two weighting methods. In the first 
water uptake characterization the C100G scaffolds showed the highest water absorption 
ability, C80HG being the second, C80HE the third and C80CSG the fourth. In the second 
water uptake characterization the C80HG scaffolds absorbed water the most, C100G as 
the second, C80CSG as the third and C80HE as the fourth. After the first four groups, rest 
of the groups were consistently in the same order in both Figures 7.16 and 7.17. Both 
water uptake characterization tests revealed that the C60CS30HE, C60CSE, C80CS15HE 
and C60HE scaffolds were the four least water absorbing groups. The slight variation in 
the results could be due to individual microstructural differences between the scaffolds 
as well as possible unintentional errors upon filter drying. 
It is evident from both Figures (7.16 and 7.17) that the compositions containing only 
60 wt.% of COL absorbed water the least. The lower water uptake capacity of the C60HE, 
C60CSE and C60CS30HE may be directly related to the amount of COL they contain. 
Both water uptake results demonstrate the higher water absorption of the 80 wt.% COL 
containing scaffolds compared to  the 60 wt.% COL containing scaffolds, which supports 
the aforementioned assumption. Also, a study by Chang et al. [13] showed that the fabri-
cated COL+HA scaffolds had increased water holding capacity with a higher concentra-
tion of COL. On the other hand HA has also been demonstrated having the ability to 
increase water uptake capacity of EDC/NHS cross-linked COL+HA scaffolds as opposed 
to plain COL scaffold [142, 127, 22]. In the present study an evidence of such effect is 
seen, again, in both water uptake characterization results. When comparing the second 
water uptake results of similarly cross-linked COL+HA scaffolds versus plain COL scaf-
folds, the C80HE scaffolds clearly show higher water uptake than the C100E scaffolds. 
Corresponding results was obtained from the first water uptake results (the scaffold and 
pore system) between the C80HE and C100E scaffolds. However, in the first water uptake 
characterization test the C80HG scaffolds demonstrated a slightly lower water uptake 
than the C100G scaffolds. The SDs of the two are relatively similar indicating that the 
results might not be because of the non-homogeneity of the parallel scaffolds. One reason 
to this could simply be that that the plain COL construct absorbs more water as a scaffold 
and pore system as opposed to scaffold only system.  
In general, the GP cross-linked scaffolds demonstrated a higher water uptake ability 
compared to most of the EDC/NHS cross-linked scaffolds; 3/4 of the GP scaffolds being 
on top four together with the C80HE group and only C80CS15HG being among the five 
least water absorbing groups. The higher water uptake ability of GP treated scaffolds is 
evident also from the photographs (shown in the Appendix 3) taken before and after im-
mersion in PBS. The highest water uptake capacity, based on the first wet weighting 
method was seen in the C100G scaffolds, and based on the second method in the C80HG 
scaffolds. According to a study by Aramwit et al. [2] GP has the ability to enhance water 
absorption capacity (and swelling) of scaffolds.  
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When comparing the results between the HA and CS containing scaffolds, the C80-scaf-
folds absorbed more water with the presence of HA than with CS. The 60 wt.% COL 
containing composite scaffolds showed similar results: C60HE/G scaffolds absorbed 
more water than C60CSE/G scaffolds. As GAGs, both HA and CS are known to attract 
water. HA needs water to hold its structure, whereas the water attracting properties of CS 
are based on the sulfate chains that ensure the water uptake of PGs in the cartilage. [50] 
Based on both of the water uptake results, CS also showed relatively promising water 
holding abilities; evident from the higher water uptake of all C80CS scaffolds versus plain 
EDC/NHS cross-linked COL scaffolds. Moreover, the difference between the C80HE and 
C80CSG scaffolds as well as between the C100E and C80CS15HG scaffolds was rela-
tively small. This suggests that compared to the plain COL scaffolds, both CS and/or HA 
may be a potential choice in order to produce scaffolds for applications in need of high 
water uptake ability (such as cartilage scaffolds).  
7.6 Dimensional change upon water uptake 
In many times, water absorption lead to swelling of the material. Any absorption that 
causes a dimensional change (swelling) may have important clinical consequences. In 
general, it is desirable that the dimensional change of a tissue engineering scaffold re-
mains relatively low. For example, a high water (meaning body fluid) absorption can 
generate significant pressure that may damage the tissue engineered material as well as 
constrain the natural healing of the tissue [90]. Figure 7.18 shows the dimensional change 
of the fabricated scaffolds upon water uptake. 
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Figure 7.18. Dimensional change percentages (change in diameter and change in height) 
of the different scaffolds upon water uptake. Diameter and height measured relative to 
the first wet weighting method. Results shown as mean ± SD. 
 
As it can be seen from Figure 7.18 most of the scaffolds swelled resulting in an increase 
in both diameter (2-12%) and in height (0-17%). However, all the scaffolds experienced 
notably different axial and radial swelling behavior. The C80CS15HG/E, C60CS30HE 
and C80CSE scaffolds swelled the least in height, while the C80CSG and C100G scaf-
folds swelled axially the most. Radial swelling was the least in the C60HE, C60CSE and 
C80CS15HE scaffolds, and the highest in the C80CS15HG, C100G and C80HG scaf-
folds. The C60HE and C60CSE scaffolds shrunk notably during wet conditions, whereas 
the C80CSE shrunk only marginally. The shrinking of the C60HE and C60CSE scaffolds 
during wet conditions may be due to a collapse of inner pores, caused by the penetrating 
of water and/or an inadequate cross-linking.  
The majority of the dimensional change results differ notably between the EDC/NHS 
and GP cross-linked scaffolds. All the scaffolds treated with either of the two crosslinkers 
showed radial increase (2-12%) upon water uptake. However, all GP treated scaffolds 
swelled more in diameter (9-12%) as opposed to the EDC/NHS cross-linked scaffolds (2-
9%). Partially corresponding results between the GP and EDC/NHS cross-linked scaf-
folds were obtained from the axial swelling behavior as well. All the GP treated scaffolds 
swelled in height; ranging from 3% to 17%, whereas the EDC-NHS treated scaffolds 
swelled only 0-12%. Moreover, three of the EDC/NHS cross-linked groups actually 
shrank in height (up to 10%). 
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In summary, all the different scaffolds swelled to some extent in diameter upon water 
uptake. Most scaffolds showed also swelling in height. However, the three groups that 
experienced shrinkage in height were C60HE (10%), C60CSE (6%) and C80CSE (±0%); 
probably caused by the collapsing of their inner porous structures upon water uptake. The 
C100G scaffolds were the group that swelled the most (d: 11%, h: 15%) as a whole and 
the C80CS15HE scaffolds the group that swelled the least (d: 6%, h: 7%). Corresponding 
to the water uptake results, the GP cross-linked scaffolds swelled overall more compared 
to the EDC/NHS cross-linked scaffolds. The more extensive swelling of the GP treated 
scaffolds is also visible from the photographs taken before and after immersion in PBS 
(see the Appendix 2). Finally, the swelling/shrinkage of all the scaffolds remained in all 
cases below 20%, and in most of the scaffolds it stayed around 10%. Dimensional changes 
of this magnitude can be considered as relatively small and acceptable for a cartilage 
tissue engineering scaffold. 
7.6 Fourier transform infrared spectroscopy  
Fourier transform infrared (FTIR) spectra was collected over a range of 450-4000 cm-1 to 
investigate differences in the biochemical compositions of scaffolds before and after 
cross-linking, demonstrating whether the cross-linking of the scaffolds was successful or 
not. FTIR measurements were performed by KBr pellet method on one scaffold per each 
EDC/NHS, GP treated and non-cross-linked scaffold group. FTIR spectra of untreated 
scaffolds were monitored to confirm the expected amide bond (cross-link) formation in 
the EDC/NHS and GP treated scaffolds. Figure 7.19 shows the FTIR spectra of all the 
scaffold groups. Additional spectral data is shown in the Appendix 6.  
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Figure 7.19. FTIR spectral data of the non-cross-linked (a), EDC/NHS cross-linked (b) 
and GP cross-linked (c) scaffolds.  
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EDC/NHS creates cross-links between molecules like COL, HA and CS by binding co-
valently carboxylic acids and amino groups to each other [87]. The cross-linking mecha-
nism of GP is yet unknown in detail but presumably it forms cross-links between amino 
groups of polypeptides [123] via another GP molecule [185]. Thus, the formation of 
cross-links through both EDC/NHS and GP treatments was monitored by analyzing the 
primary (I) amide and secondary amide (II) bands; showing characteristic peaks at 1670-
1620 cm-1 and 1570-1515 cm-1 [52]. These bands are assigned with the primary amines 
(NH2) being converted to amide bonds (N-H) during the formation of cross-links [89]. In 
addition to amide bonds, EDC (and possibly GP as well) seems to mediate acid anhydride 
formation between two carboxyl groups belonging to the same or different polysaccharide 
molecules (in this case HA and CS). The resultant acid anhydride may readily react with 
a hydroxyl group of HA and CS to yield an ester bond, which functions as a cross-link in 
a polysaccharide molecule. [107]  
Some of the peaks were clearly visible in the FTIR spectra of all of the scaffolds, and 
always around the same wavenumbers. The spectra of both cross-linked and non-cross-
linked CS containing scaffolds included similar distinctive peaks at ~1240 cm-1 due to 
S=O stretching in CS molecules [132]. In all of the spectra of the different scaffolds, there 
were wide peaks at 3600-3200 cm-1 present. This band is assigned with primary amines 
(NH2), and the prominent peaks are due to amide N-H stretching. [52] The spectra of both 
EDC/NHS and GP cross-linked scaffolds showed similar peaks at ~700 cm-1 due to out-
of-plane bending of N-H; at 1670-1620 cm-1 due to bending of amide I bonds; at 1570-
1515 cm-1 due to amide II bonds; and at around 1200 cm-1 due to C-O bonds [52]. Similar 
distinctive peaks between all the different scaffolds were detected with non-cross-linked 
scaffolds at 3750-3600 cm-1 due to free hydroxyl and carboxyl groups [52]; Figure 7.19 
(a). These peaks are seen leveled down in the spectra of both cross-linked scaffolds due 
to associations with other molecules (cross-links). 
Intermolecular cross-links formed between the carboxyl, hydroxyl and amino groups 
of the COL, HA and/or CS molecules were observed on all of the different scaffolds after 
both cross-linking treatments. In particular, the spectra of all the cross-linked scaffolds 
showed characteristic peaks at 1670-1620 cm-1 (amide I band) and 1570-1515 cm-1 (am-
ide II band), indicating formation of amide bonds (cross-links) [52]. The amide I band of 
COL is sensitive to the change of secondary structure. The shifts of characteristic amide 
I band positions (at 1690-1640 cm-1) in the spectra of C80CS15HE scaffolds could sug-
gest a conformational change of COL and the existence of interactions between COL, HA 
and CS. [132]  
The bands corresponding to ester cross-links between COL, HA and/or CS molecules 
are present on the FTIR spectra of all the different scaffolds. Specifically, several peaks 
can be detected at 970-1300 cm-1 in the spectra of all cross-linked scaffolds suggesting 
ester bonds between carboxyl and hydroxyl groups [89] of COL, HA and/or CS mole-
cules. Some of the peaks observed especially at 1440-1210 cm-1 may also be due to the 
carboxyl groups of COL, HA and/or CS. The stretching of C-O combined with the bend-
ing of C-OH is known to generate distinctive peaks at the aforementioned band [52]. 
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Unfortunately, between 1300-970 cm-1 there are several peaks in the spectra of the scaf-
folds and some peak positions are very close to each other. As a result it is difficult to 
identify all individual bands.  
A noticeable difference seen between the spectra of non-cross-linked (Figure 7.19 (a)) 
and cross-linked scaffolds (Figure 7.19 (b) and (c)) was a cluster of peaks at 3750-3600 
cm-1; visible only in the spectra of non-cross-linked scaffolds. They result from free hy-
droxyl (-OH) and carboxyl groups (-COOH) or more specifically from the stretching of 
O-H involved [52]. Since the carboxyl and hydroxyl groups become associated (instead 
of remaining free) during cross-linking, these peaks are leveled in the cross-linked spec-
tra. It should be noted that the distinctive peaks at 2300-2400 cm-1 seen in all of the spectra 
were caused by the FTIR measuring device and are not associated with the molecular 
composition of the scaffolds. 
In summary, spectra of the different scaffolds all demonstrated characteristic peaks 
corresponding to amide bond formation (at 1670-1620 cm-1 and 1570-1515 cm-1). Fur-
thermore, in the spectra of the non-cross-linked scaffolds peaks assigned to free hydroxyl 
(-OH) and carboxyl groups (-COOH) (at 3750-3600 cm-1) were seen leveled down in the 
spectra of the cross-linked scaffolds due to the forming of cross-links. These observations 
supported the conclusion that both crosslinkers (EDC/NHS and GP) produced success-
fully cross-linked scaffolds and that the different compositions/components of the scaf-
folds did not affect the cross-linking mechanisms. 
The degree of cross-linking was not analyzed in the present study because it would 
have required additional methods. Possibilities for a subsequent analysis on the degree of 
cross-linking is to use DSC and/or TG measurements to study the denaturation tempera-
ture (Td) of the scaffolds [22, 63] or to use an equation by Aramwit et al. [2] exploiting 
absorbance values of FTIR measurements. In addition, it is possible to calculate a D value 
between intensities of deformation vibration and amide, which reflects the content of the 
primary amine [56].  
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CONCLUSIONS  
In the present study COL-based scaffolds with HA and/or CS were successfully fabricated 
by freeze-drying and cross-linked with EDC/NHS and GP. The best looking 
COL+HA/CS/CS+HA scaffolds were fabricated with the blends of 1.0 wt.% COL, HA 
and/or CS. In general, the 80 wt.% COL containing scaffolds endured the fabrication and 
cross-linking procedures better than the 60 wt.% COL containing scaffolds. The GP 
cross-linked plain COL and the EDC/NHS cross-linked COL+HA scaffolds maintained 
their original size and shape the best after the cross-linking treatment, whereas the least 
successful cross-linked scaffolds were the CS containing composite scaffolds.  
The FTIR spectra of all the scaffolds demonstrated that the varying composi-
tions/components did not affect the cross-linking mechanism and that successful cross-
linking was established in all of the scaffolds with both cross-linking treatments. The 
micro-CT images showed highly porous and interconnected microstructure in all of the 
scaffolds. COL+HA scaffolds demonstrated higher porosity (91-94%) compared to 
COL+CS scaffolds (89-91%). In general, GP treated scaffolds had smaller pores (less 
than 40 µm) compared to EDC/NHS cross-linked scaffolds.  
The 60 wt.% COL containing scaffolds absorbed water the least. The GP treated scaf-
folds had higher water uptake capacity compared to the corresponding EDC/NHS scaf-
folds. This suggests that GP could possibly be particularly favorable choice as a cross-
linker as opposed to the conventional EDC/NHS treatment; in terms of increasing the 
water uptake capacity of COL-based scaffolds. Furthermore, the results from both water 
uptake characterizations demonstrated that with the inclusion of HA and/or CS into COL 
the water uptake capacity of the scaffolds could be increased as opposed to plain COL 
scaffolds.  
Corresponding to the water uptake results, the GP cross-linked scaffolds generally 
swelled more compared to the EDC/NHS cross-linked scaffolds. The swelling/shrinkage 
of all the scaffolds remained below 20%, and in most cases it was only around 10%. In 
general, the COL+HA scaffolds recovered slightly better from the compression than the 
COL+CS scaffolds. All the scaffolds recovered very well after the compression (up to 
85-100% to their initial size); only the dry scaffolds recovered slightly poorer in terms of 
height. All the dimensional change results were considered acceptable for a tissue engi-
neering cartilage scaffold. 
In general, in terms of both dry and wet measurements the COL+CS scaffolds demon-
strated superior compressive properties compared to the corresponding COL+HA scaf-
folds. Supposedly the presence of either CS or HA in the composite affected more on the 
compressive properties of the scaffolds than either of the cross-linking treatments. Fur-
thermore, there was no clear correlation between the compressive modulus and the two 
cross-linking treatments; both demonstrated low and high values, respectively. All the 60 
wt.% COL containing scaffolds demonstrated similar compressive stiffness in both dry 
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and wet states, while rest of the dry scaffolds demonstrated approximately 3-4 times 
higher stiffness compared to the corresponding wet scaffolds. The compressive stiffness 
results showed a strong correlation with the water uptake results; the scaffolds that 
demonstrated low water absorption exhibited in high compressive stiffness and vice 
versa. 
In general, the results obtained from the microstructure, dimensional changes upon 
water uptake, recovery from compression and FTIR characterizations did not differ sig-
nificantly between the scaffold groups. However, based on the results obtained from fab-
rication, cross-linking and water uptake characterization, the 80 wt.% COL containing 
composite scaffolds showed superior properties over the 60 wt.% containing composite 
scaffolds. It should be noted that the small size and soft nature of the fabricated scaffolds 
as well as the vast variety of non-homogenous scaffolds per each test group challenged 
the characterization and resulted in high SDs of some of the results. 
The composition of COL+CS+HA was considered particularly interesting because in 
theory it mimics closest the composition of a native cartilage matrix. On the other hand, 
as a product a COL+CS+HA scaffold might be difficult to implement, since its fabrication 
involves inclusion of three individual components. So far there has been only a small 
amount of studies reported concerning this particular combination, but the results from 
those studies have been promising and encourage towards further studies. Also, in the 
present work the results obtained from the compression, water uptake (scaffold and the 
pore system), recovery from compression, FTIR, micro-CT and dimensional change upon 
water uptake tests of the C80CS15HE/G scaffolds were promising.  
Further in vitro and in vivo studies are recommended for the 80 wt.% COL containing 
composite scaffolds. Following tests are suggested to be added to the ones performed in 
the present study: degradation studies, scanning electron microscope imaging (SEM) and 
in vitro cell tests as well at some point. The novel cross-linker GP proved to be a promis-
ing alternative for the conventional EDC/NHS cross-linker; GP did not only produce suc-
cessfully cross-linked scaffolds but it also increased the water absorption ability of the 
scaffolds. Furthermore, the fact that GP is a natural cross-linking agent makes its use even 
more beneficial in order to produce tissue engineered scaffolds with the best possible 
biological properties. Finally, the use of COL type II instead of COL type I (used in the 
present study) is suggested for further studies on the COL-based CS and/or HA scaffolds. 
Since the native cartilage tissue is composed of type II COL, this approach could possibly 
further support chondrogenesis, and ultimately lead to better results with future in vivo 
experiments.  
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APPENDIX 1: SCAFFOLDS BEFORE AND AFTER CROSS-LINKING 
 
The photographs below demonstrate the general impact that the cross-linking treatment 
had on each scaffold group. The scaffolds were photographed in mixed order before and 
after cross-linking, and therefore the before and after photographs should not be compared 
as scaffold per scaffold. Abbreviation ‘CL’ in the caption text stands for cross-linking. 
 
C100 scaffolds before EDC/NHS CL         C100 scaffolds after EDC/NHS CL  
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C100 scaffolds before GP CL          C100 scaffolds after GP CL  
 
       
 
       
 
C80H scaffolds before EDC/NHS CL  C80H scaffolds after EDC/NHS CL  
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C60H scaffolds before EDC/NHS CL  C60H scaffolds after EDC/NHS CL  
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C80CS scaffolds before GP CL         C80CS scaffolds after GP CL  
 
       
 
       
 
C60CS scaffolds before EDC/NHS CL  C60CS scaffolds after EDC/NHS CL  
 
       
 
       
 
C80CS15H scaffolds before EDC/NHS CL   C80CS15H scaffolds after EDC/NHS CL  
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C60CS30H scaffolds before EDC/NHS CL   C60CS30H scaffolds after EDC/NHS CL  
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APPENDIX 2: PHOTOGRAPHS TAKEN FROM THE SCAFFOLDS IN 
DRY, SOAKING WET AND FILTER DRIED STATE 
 
Adjacent images represent one scaffold from each scaffold group; photographed in dry, 
soaking wet (SW) and filter dried (FD) state. SW shows the scaffold after immersion in 
PBS (pH 7.4) for 24 hours and FD after drying between filter papers. 
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APPENDIX 3: COMPRESSIVE STRESS-STRAIN CURVES OF THE 
DRY SCAFFOLDS 
 
Numbers appearing in each figure (from #01 to #06) stand for parallel scaffolds within 
each test group. 
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APPENDIX 4: COMPRESSIVE STRESS-STRAIN CURVES OF THE 
WET SCAFFOLDS 
 
Numbers appearing in each figure (from #01 to #06) stand for parallel scaffolds within 
each test group. 
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APPENDIX 5: MICRO-COMPUTED TOMOGRAPHY IMAGES OF 
THE SCAFFOLDS 
 
Image shown on top left represent a partial 3D reconstruction of the scaffold taken from 
1 mm x 1 mm x 1 mm area of the scaffold (scale bar = 500 µm). The other three images 
are 2D photographs taken from different areas of the scaffold (scale bar = 300 µm). 
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APPENDIX 6: FOURIER TRANSFORM INFRARED SPECTRA OF 
THE SCAFFOLDS 
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APPENDIX 7: COMPARABLE COMPRESSIVE MODULUS RE-
SULTS 
 
All the scaffolds presented in the table below are cylindrical shaped. Abbreviations used 
in the table: d = diameter, h = height, ADH = adipic dihydrazide and DHT = dehydro-
thermal.  
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APPENDIX 8: REPORTED GENIPIN CROSS-LINKING PROCE-
DURES 
 
Abbreviations used in the table: Chi = chitosan, CL = cross-linking, DMEM = Dulbecco’s 
modified Eagle's medium, DPBS = Dulbecco's PBS, ELN = elastin, Gel = gelatin, TE = 
tissue engineering and ELAC = electronically aligned collagen. 
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APPENDIX 9: STUDIES REPORTED ON COLLAGEN-HYALURONIC 
ACID SCAFFOLDS  
 
ABBREVIATIONS  
 
All the initial concentrations of blends as well as the final composition ratios of composite 
scaffolds are noted in the table according to original source. Abbreviations used in the 
table: AFM = atomic force microscopy, CL = cross-linking, COL1 = collagen type I, 
COL2 = collagen type II, dH2O = distilled water, DIW = deionized water, Gel = gelatin, 
GMHA = glycidyl methacrylate-modifed hyaluronic acid, HCPDE = hollow-centered 
parallel disc electrode, IPN = interpenetrating polymeric network, PEM = polyelectrolyte 
multilayer, PIC = polyion complex, PU = polyurethane, (E)SEM = environmental scan-
ning electron microscopy, TE = tissue engineering and UNS = unspecified. 
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APPENDIX 10: STUDIES REPORTED ON COLLAGEN-CHON-
DROITIN SULFATE SCAFFOLDS  
 
All the initial concentrations of blends as well as the final composition ratios of composite 
scaffolds are noted in the table according to original source. Abbreviations used in the 
table: BP = benzophenone, CDI = 1,1-carbonyldiimidazole, Chi = chitosan, CL = cross-
linking, COL1 = collagen type I, COL2 = collagen type II, ELN = elastin, (E)SEM = 
(environmental) scanning electron microscopy, TE = tissue engineering and UNS = un-
specified. 
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APPENDIX 11: STUDIES REPORTED ON COLLAGEN-HYALU-
RONIC ACID/CHONDROITIN SULFATE SCAFFOLDS  
 
All the initial concentrations of blends as well as the final composition ratios of composite 
scaffolds are noted in the table according to original source. Abbreviations used in the 
table: CL = cross-linking, COL1 = collagen type I, COL2 = collagen type II, TE = tissue 
engineering and UNS = unspecified. 
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APPENDIX 12: STUDIES REPORTED ON COLLAGEN-CHON-
DROITIN SULFATE-HYALURONIC ACID SCAFFOLDS  
 
All the initial concentrations of blends as well as the final composition ratios of composite 
scaffolds are noted in the table according to original source. Abbreviations used in the 
table: ADH = adipic dihydrazide, CL = cross-linking, COL1 = collagen type I, COL2 = 
collagen type II, CSMA = chondroitin sulfate methacrylic anhydride, dH2O = distilled 
water, HAMA = hyaluronic acid methacrylic anhydride, IPN = interpenetrating polymeric 
network, TE = tissue engineering and UNS = unspecified. 
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